Drug Name,SMILES,LiverTox Summary Statement,Hepatotoxicity Class,CAS,Alert 1,Alert 2,Alert 3,Alert 4,Alert 5,Alert 6,Alert 7,Alert 8,Alert 9,Alert 10,Alert 11,Alert 12,SPLIT,label
Acamprosate,OS(=O)(=O)CCCNC(=O)C,Acamprosate has been not been linked to serum enzyme elevations during therapy and has not been linked to cases of clinically apparent liver injury,-1,CAS 77337-76-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Moexipril,C(c1ccccc1)C[C@H](N[C@H](C(N1Cc2c(C[C@H]1C(O)=O)cc(OC)c(c2)OC)=O)C)C(OCC)=O,"Moexipril is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",-1,CAS 103775-10-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Quinapril,N1([C@@H](Cc2ccccc2C1)C(O)=O)C([C@@H](N[C@@H](CCc1ccccc1)C(OCC)=O)C)=O.Cl,"Quinapril is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",-1,CAS 85441-61-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Trandolapril,C1CC[C@@H]2C[C@H](N([C@@H]2C1)C([C@H](C)N[C@@H](CCc1ccccc1)C(OCC)=O)=O)C(=O)O,"Trandolapril is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",-1,CAS 87679-37-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Aclidinium,C1C[N+]2(CCC1[C@H](C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],Aclidinium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 320345-99-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Acrivastine,O=C(O)\C=C\c3nc(\C(=C\CN1CCCC1)c2ccc(cc2)C)ccc3,Acrivastine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 87848-99-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Acyclovir,c1nc2c(=O)[nH]c(nc2n1COCCO)N,Acyclovir has not been associated with clinically apparent liver injury.,-1,CAS 59277-89-3,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Adefovir,c12c(ncn1CCOCP(O)(O)=O)c(ncn2)N,"Adefovir does not appear to be a significant cause of drug-induced liver injury, but initiation of therapy and sudden withdrawal of therapy can induce a transient exacerbation of the underlying hepatitis B.",-1,CAS 106941-25-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Albuterol,CC(C)(C)NCC(c1ccc(c(c1)CO)O)O,Their use in asthma has not been associated with liver injury.,-1,CAS 18559-94-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Salmeterol,c1(cc(c(O)cc1)CO)[C@@H](CNCCCCCCOCCCCc1ccccc1)O,Their use in asthma has not been associated with liver injury.,-1,CAS 89365-50-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Xinafoate,c12c(c(c(C(O)=O)cc1)O)cccc2,Their use in asthma has not been associated with liver injury.,-1,CAS 86-48-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Terbutaline,c1([C@@H](C[NH2+]C(C)(C)C)O)cc(cc(c1)O)O,Their use in asthma has not been associated with liver injury.,-1,CAS 23031-25-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Aliskiren,C([C@@H](C[C@H](N)[C@H](C[C@@H](C(NCC(C(N)=O)(C)C)=O)C(C)C)O)C(C)C)c1ccc(OC)c(OCCCOC)c1,Aliskiren has yet to be linked definitively to either serum aminotransferase elevations or clinically apparent liver injury.,-1,CAS 173334-57-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Mechlorethamine,N(CCCl)(CCCl)C,"The combination of mechlorethamine with other antineoplastic agents has been associated with low rates of serum enzyme elevations during therapy, but mechlorethamine has not been implicated specifically in cases of acute, clinically apparent injury.",-1,CAS 51-75-2,0,0,0,0,0,0,0,0,1,0,0,0,train,0
Doxazosin,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1,"Doxazosin is associated with a low rate of transient serum aminotransferase elevations, but has not been linked to instances of clinically apparent acute liver injury.",-1,CAS 74191-85-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Prazosin,COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)c4ccco4,Prazosin is associated with a low rate of transient serum aminotransferase elevations and has not been clearly linked to clinically apparent acute liver injury.,-1,CAS 19216-56-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Bumetanide,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,"Clinically apparent acute liver injury due to the loop diuretics is exceeding rare, if it occurs at all.",-1,CAS 28395-03-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ethacrynic Acid,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,"Clinically apparent acute liver injury due to the loop diuretics is exceeding rare, if it occurs at all.",-1,CAS 58-54-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Furosemide,c1(c(cc(c(c1)S(=O)(=O)N)Cl)NCc1ccco1)C(=O)O,"Clinically apparent acute liver injury due to the loop diuretics is exceeding rare, if it occurs at all.",-1,CAS 54-31-9,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Torsemide,Cc1cccc(c1)Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C,"Clinically apparent acute liver injury due to the loop diuretics is exceeding rare, if it occurs at all.",-1,CAS   56211-40-6,0,0,0,1,0,0,0,0,0,0,0,0,train,0
Betaxolol,c1(ccc(cc1)CCOCC1CC1)OCC(CNC(C)C)O,Betaxolol has not been linked to instances of clinically apparent drug-induced liver injury.,-1,CAS 63659-18-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Bisoprolol,CC(C)NCC(COc1ccc(cc1)COCCOC(C)C)O,Bisoprolol has not been linked to instances of clinically apparent drug-induced liver injury.,-1,CAS 66722-44-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Esmolol,c1(ccc(CCC(OC)=O)cc1)OC[C@@H](CNC(C)C)O,Esmolol has not been linked to instances of clinically apparent drug-induced liver injury.,-1,CAS 103598-03-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Nadolol,c12c(C[C@@H](O)[C@H](C2)O)cccc1OC[C@@H](CNC(C)(C)C)O,Nadolol has yet to be convincingly associated with clinically apparent liver injury.,-1,CAS 42200-33-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Nebivolol,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,Nebivolol has yet to be linked to instances of clinically apparent liver injury.,-1,CAS 99200-09-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Penbutolol,C([C@H](CNC(C)(C)C)O)Oc1ccccc1C1CCCC1,Penbutolol has yet to be convincingly associated with clinically apparent liver injury.,-1,CAS 36507-48-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Pindolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,Pindolol has yet to be convincingly associated with clinically apparent liver injury.,-1,CAS 13523-86-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Propranolol,c12c(OC[C@@H](CNC(C)C)O)cccc1cccc2,Propranolol has yet to be convincingly associated with clinically apparent liver injury and is often used in patients with liver disease and cirrhosis.,-1,CAS 525-66-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Timolol,c1(c(OC[C@H](CNC(C)(C)C)O)nsn1)N1CCOCC1.c1(c(OC[C@H](CNC(C)(C)C)O)nsn1)N1CCOCC1.O,Timolol has yet to be convincingly associated with clinically apparent liver injury and is often used in patients with liver disease and cirrhosis.,-1,CAS 26839-75-8,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Clonidine,c1(NC2=NCCN2)c(cccc1Cl)Cl,"Despite wide scale use for many years, clonidine has not been linked definitively to either serum aminotransferase elevations or clinically apparent liver injury.",-1,CAS 4205-90-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Reserpine,c12[C@@H]3[N@@](C[C@H]4C[C@@H](OC(c5cc(c(OC)c(c5)OC)OC)=O)[C@@H]([C@H]([C@@H]4C3)C(OC)=O)OC)CCc1c1ccc(cc1[nH]2)OC,"Despite wide scale use for many years, reserpine has not been shown to cause clinically apparent liver injury.",-1,CAS 50-55-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Azilsartan,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1,"It is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",-1,CAS 147403-03-0,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Eprosartan,s1cccc1CC(=C\c1n(c(nc1)CCCC)Cc1ccc(C(O)=O)cc1)\C(O)=O,Eprosartan is associated with a low rate of transient serum aminotransferase elevations but has yet to be linked to instances of acute liver injury.,-1,CAS 133040-01-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Olmesartan,CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4[nH]nnn4)C(=O)O)C(C)(C)O,"Olmesartan is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",-1,CAS 144689-63-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Telmisartan,n1(c(nc2c1cccc2)c1cc(c2c(n(c(CCC)n2)Cc2ccc(cc2)c2c(cccc2)C(O)=O)c1)C)C,"Telmisartan is associated with a low rate of transient serum aminotransferase elevations, but has yet to be linked to instances of acute liver injury.",-1,CAS 144701-48-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)c2cccc3c2non3)C(=O)OC,Isradipine is associated with a low rate of serum enzyme elevations during therapy but has not been specifically linked to clinically apparent liver injury.,-1,CAS 75695-93-1,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)Cc2ccccc2)c3cccc(c3)[N+](=O)[O-])C(=O)OC,Nicardipene therapy has been associated with a low rate of transient serum enzyme elevations but has not been specifically linked to clinically apparent liver injury with jaundice.,-1,CAS 55985-32-5,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Nisoldipine,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)c2ccccc2[N+](=O)[O-])C(=O)OC,Nisoldipine therapy is associated with a low rate of serum enzyme elevations but has not been specifically linked to instances of clinical apparent acute liver injury.,-1,CAS 63675-72-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Felodipine,CCOC(=O)C1=C(NC(=C(C1c2cccc(c2Cl)Cl)C(=O)OC)C)C,"Felodipine therapy has been associated with a low rate of serum enzyme elevations but has not been convincingly linked to instances of clinically apparent, acute liver injury.",-1,CAS 72509-76-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Minoxidil,c1(N2CCCCC2)cc(n(=O)c(n1)N)N,"Despite its use for many years, minoxidil has not been convincingly linked to cases of clinically apparent liver injury.",-1,CAS 38304-91-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Dutasteride,C1=C[C@]2([C@H](NC1=O)CC[C@@H]1C2CC[C@]2([C@H]1CC[C@@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F)C)C,Dutasteride is associated with a low rate of transient serum aminotransferase elevations but has yet to be linked to instances of clinically apparent acute liver injury.,-1,CAS 164656-23-9,1,0,0,0,0,0,0,0,1,0,0,0,train,0
Finasteride,[C@H]12[C@H]3[C@@H]([C@@]4([C@@H](CC3)NC(=O)C=C4)C)CC[C@@]1([C@H](CC2)C(=O)NC(C)(C)C)C,"Finasteride is associated with a low rate of transient serum aminotransferase elevations but has yet to be linked to instances of clinically apparent, acute liver injury.",-1,CAS 98319-26-7,1,0,0,0,0,0,0,0,0,0,0,0,train,0
Miglitol,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,Miglitol has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 72432-03-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Galantamine,CN1CC[C@@]23C=C[C@@H](C[C@@H]2Oc4c3c(ccc4OC)C1)O,Galantamine is associated with a minimal rate of serum enzyme elevations during therapy and has not been implicated as a cause of clinically apparent liver injury.,-1,CAS 357-70-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Amantadine,C1C2CC3CC1CC(C3)(C2)N,Amantadine has not been associated with clinically apparent liver injury.,-1,CAS 768-94-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ambrisentan,O=C(O)[C@@H](Oc1nc(cc(n1)C)C)C(OC)(c2ccccc2)c3ccccc3,"Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy, but has yet to be implicated in cases of clinically apparent acute liver injury.",-1,CAS 177036-94-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Amikacin,O=C(N[C@H]3[C@H](O[C@H]1O[C@@H]([C@@H](O)[C@H](N)[C@H]1O)CO)[C@@H](O)[C@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](N)C3)[C@@H](O)CCN,"Despite widespread use, amikacin has not been associated with instances of acute liver injury.",-1,CAS 37517-28-5,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Gentamicin,CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1,"Despite its wide use, gentamicin has not been definitively linked to instances of clinically apparent liver injury.",-1,CAS 1403-66-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Neomycin,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,Neomycin has minimal oral absorption and its use has not been linked to instances of acute liver injury.,-1,CAS 1404-04-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Streptomycin,O([C@@H]1[C@@H]([C@H]([C@H](O)[C@H](O1)CO)O)NC)[C@@H]1[C@H](O[C@@H]([C@]1(C=O)O)C)O[C@@H]1[C@H]([C@@H]([C@@H](NC(N)=N)[C@@H]([C@H]1O)O)O)NC(N)=N,"Streptomycin is usually used in combination with agents that are known to be hepatotoxic and the role of streptomycin in liver injury has been difficult to assess, but most information suggests that streptomycin is not hepatotoxic.",-1,CAS 57-92-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Tobramycin,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,"Despite its wide use, tobramycin has rarely been linked to instances of clinically apparent liver injury.",-1,CAS 32986-56-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Amobarbital,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,There have been no reports of liver injury associated with secobarbital or amobarbital. ,-1,CAS 57-43-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,There have been no reports of liver injury associated with secobarbital or amobarbital. ,-1,CAS 76-73-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Amphotericin B,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,"Amphotericin B commonly causes mild to moderate serum aminotransferase elevations and can cause hyperbilirubinemia, but acute, clinically apparent drug induced liver injury from amphotericin B therapy is exceedingly rare.",-1,CAS 1397-89-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Anidulafungin,c1(ccc(OCCCCC)cc1)c1ccc(c2ccc(cc2)C(N[C@H]2C[C@@H](O)[C@@H](O)NC([C@@H]3[C@H]([C@H](CN3C([C@@H]([C@H](C)O)NC([C@@H](NC(=O)[C@H]3N(C([C@@H](NC2=O)[C@@H](C)O)=O)C[C@@H](O)C3)[C@@H]([C@H](c2ccc(cc2)O)O)O)=O)=O)C)O)=O)=O)cc1,"All three agents can cause transient and asymptomatic serum aminotransferase elevations, and individual instances of acute liver injury have been observed during therapy with these agents, but none has been definitely shown to cause clinically apparent acute drug induced liver injury.",-1,CAS 166663-25-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Caspofungin,C(CN)[C@H]([C@@H]1NC(=O)[C@@H]([C@H](O)[C@H](c2ccc(cc2)O)O)NC([C@H]2N(C([C@@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)C[C@H]([C@@H](NC([C@@H]3[C@H](CCN3C1=O)O)=O)NCCN)O)=O)C[C@@H](C2)O)=O)O,"All three agents can cause transient and asymptomatic serum aminotransferase elevations, and individual instances of acute liver injury have been observed during therapy with these agents, but none has been definitely shown to cause clinically apparent acute drug induced liver injury.",-1,CAS 179463-17-3,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Micafungin,CCCCCOc1ccc(cc1)c2cc(no2)c3ccc(cc3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(c7ccc(c(c7)OS(=O)(=O)O)O)O)O)C(CC(=O)N)O)C)O)O)O,"All three agents can cause transient and asymptomatic serum aminotransferase elevations, and individual instances of acute liver injury have been observed during therapy with these agents, but none has been definitely shown to cause clinically apparent acute drug induced liver injury.",-1,CAS 235114-32-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Theophylline,c12c(n(c(=O)n(c1=O)C)C)nc[nH]2,Theophylline is widely used in therapy of asthma and is not believed to cause liver injury.,-1,CAS 58-55-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Atropine,CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)C(CO)c2ccccc2,Atropine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 51-55-8,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,Darifenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 133099-04-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,Dicyclomine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 77-19-0,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Fesoterodine,O=C(Oc1ccc(cc1[C@@H](c2ccccc2)CCN(C(C)C)C(C)C)CO)C(C)C,Fesoterodine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 286930-02-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Flavoxate,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,Flavoxate has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 15301-69-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Glycopyrrolate,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,Glycopyrrolate has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 596-51-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Hyoscyamine,CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)[C@H](CO)c2ccccc2,Hyoscyamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 101-31-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ipratropium,[Br-].[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N@+]2(C)C(C)C,Ipratropium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 60205-81-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Mepenzolate,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,Mepenzolate has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 25990-43-6,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,Oxybutynin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 5633-20-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=CC=CC=C12)C(C)C,Propantheline has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 298-50-0,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Scopolamine,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,Scopolamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 51-34-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Methscopolamine,[Br-].[H][C@]12C[C@@H](C[C@@]([H])(C3OC13)[N+]2(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,Scopolamine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 155-41-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Solifenacin,OC(=O)CCC(O)=O.O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,Solifenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 242478-37-1,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Tiotropium,C[N+]1(C)[C@H]2CC(C[C@@H]1[C@@H]1O[C@H]21)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,Tiotropium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 186691-13-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Tolterodine,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,Tolterodine has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 124937-51-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Trospium,OC(C(=O)OC1CC2CCC(C1)[N+]21CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,Trospium has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.,-1,CAS 10405-02-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Dipyridamole,c1cc(cc2c1n(c(n2)CNc1ccc(cc1)C(=N)N)C)C(=O)N(CCC(=O)O)c1ncccc1,"Dipyridamole is associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",-1,CAS 58-32-2,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Fondaparinux,S(=O)(=O)(O)OC[C@@H]1[C@H]([C@@H]([C@@H](NS(=O)(=O)O)[C@H](O1)OC)O)O[C@H]1[C@H](OS(=O)(=O)O)[C@H]([C@@H]([C@H](C(=O)O)O1)O[C@@H]1[C@H](NS(=O)(=O)O)[C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O)O)NS(=O)(=O)O)C(=O)O)OS(=O)(=O)O)O,"Fondaparinux has been associated with a low rate of serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent, idiosyncratic liver injury.",-1,CAS 242138-07-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Clonazepam,c1ccc(c(c1)C2=NCC(=O)Nc3c2cc(cc3)[N+](=O)[O-])Cl,"Therapy with clonazepam is not associated with serum aminotransferase elevations, and clinically apparent liver injury from clonazepam, if it occurs at all, must be exceedingly rare.",-1,CAS 1622-61-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ethosuximide,C1([C@@](CC(=O)N1)(CC)C)=O,Ethosuximide has been associated with rare instances of serum enzyme elevations during treatment but has not been linked to cases of clinically apparent liver injury with jaundice.,-1,CAS 77-67-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Primidone,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,"Therapy with primidone can be associated with increases in gamma glutamyltranspeptidase levels, but is not associated with serum aminotransferase elevations, and despite its similarity in structure to phenobarbital and phenytoin, clinically apparent liver injury from primidone has not been reported and must be exceedingly rare if it occurs at all.",-1,CAS 125-33-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Tiagabine,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,"Therapy with tiagabine is not associated with serum aminotransferase elevations, and clinically apparent liver injury from tiagabine has not been reported and must be very rare if it occurs at all.",-1,CAS 115103-54-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Colchicine,c12c3c([C@H](CCc2cc(c(c1OC)OC)OC)NC(=O)C)cc(=O)c(cc3)OC,Colchicine has not been associated with acute liver injury or liver test abnormalities except with serious overdoses.,-1,CAS 64-86-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Febuxostat,s1c(nc(c1C(=O)O)C)c1cc(c(cc1)OCC(C)C)C#N,"Chronic febuxostat therapy has been associated with minor serum aminotransferase elevations, but has yet to be linked to cases of clinically apparent acute liver injury.",-1,CAS 144060-53-7,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Probenecid,c1(S(=O)(=O)N(CCC)CCC)ccc(cc1)C(=O)O,"Probenecid has been associated with minor serum aminotransferase elevations and very rarely with hypersensitivity reactions which, even more rarely, can be accompanied by acute liver injury.",-1,CAS 57-66-9,0,0,0,1,0,0,0,0,0,0,0,0,train,0
Nitazoxanide,c1(c(cccc1)OC(C)=O)C(Nc1sc([N+]([O-])=O)cn1)=O,Nitazoxanide therapy has not been reported to cause serum aminotransferase elevations during therapy or clinically apparent liver injury.,-1,CAS 55981-09-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Praziquantel,c12[C@@H]3N(C(CN(C3)C(C3CCCCC3)=O)=O)CCc1cccc2,"Praziquantel therapy has been reported to cause serum aminotransferase elevations during therapy, but clinically apparent liver injury after its use is rare if it occurs at all.",-1,CAS 55268-74-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Pyrantel,C=1(\C=C\c2cccs2)N(CCCN1)C,Pyrantel therapy has not been reported to cause serum aminotransferase elevations or clinically apparent liver injury.,-1,CAS 15686-83-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Brompheniramine,Brc1ccc(cc1)C(c2ncccc2)CCN(C)C,Clinically apparent liver injury from brompheniramine or chlorpheniramine must be exceeding rare if it occurs at all.,-1,CAS 86-22-6,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Chlorpheniramine,Clc1ccc(cc1)C(c2ncccc2)CCN(C)C,Clinically apparent liver injury from brompheniramine or chlorpheniramine must be exceeding rare if it occurs at all.,-1,CAS 132-22-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Carbinoxamine,Clc1ccc(cc1)C(OCCN(C)C)c2ncccc2,Carbinoxamine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 486-16-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Clemastine,Clc1ccc(cc1)[C@](OCC[C@@H]2N(C)CCC2)(c3ccccc3)C,Clemastine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 15686-51-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Diphenhydramine,O(CCN(C)C)C(c1ccccc1)c2ccccc2,Diphenhydramine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 58-73-1,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Doxylamine,O(CCN(C)C)C(c1ncccc1)(c2ccccc2)C,Doxylamine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 469-21-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Hydroxyzine,Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCCO,Hydroxyzine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 68-88-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Meclizine,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,Meclizine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 569-65-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Phenyltoloxamine,O(c1ccccc1Cc2ccccc2)CCN(C)C,Phenyltoloxamine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 92-12-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Promethazine,S2c1ccccc1N(c3c2cccc3)CC(N(C)C)C,"Despite its phenothiazine structure, promethazine has not been linked to instances of clinically apparent acute liver injury.",-1,CAS 60-87-7,0,0,0,0,0,0,0,0,0,0,0,1,test,0
Triprolidine,n3c(\C(=C\CN1CCCC1)c2ccc(cc2)C)cccc3,Triprolidine has not been linked to instances of clinically apparent acute liver injury.,-1,CAS 486-12-4,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Colestipol,C1C(O1)CCl.NCCNCCNCCNCCN,Colestipol has not been associated with clinically apparent liver injury.,-1,CAS 50925-79-6,0,0,0,0,0,0,0,0,1,0,0,0,train,0
Primaquine,CC(CCCN)Nc1cc(cc2c1nccc2)OC,Primaquine is not associated with serum enzyme elevations during therapy and has yet to be linked to instances of clinically apparent acute liver injury.,-1,CAS 90-34-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Daunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)C)O)N)O,"Daunorubicin is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury with jaundice.",-1,CAS 20830-81-3,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Mitomycin,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,"Mitomycin in combination with other anticancer agents frequently causes mild-to-moderate serum enzyme elevations during therapy and is capable of causing sinusoidal obstruction syndrome, but mitomycin by itself has not been specifically linked to instances of clinically apparent liver injury with jaundice.",-1,CAS 50-07-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Capecitabine,[C@H]1(n2c(=O)nc(c(c2)F)NC(=O)OCCCCC)[C@@H]([C@@H]([C@H](O1)C)O)O,Capecitabine is associated with a low rate of transient serum aminotransferase elevations during therapy but has been only rarely implicated in cases of clinically apparent acute liver injury.,-1,CAS 154361-50-9,0,0,0,0,0,0,0,0,1,0,0,0,test,0
Cytarabine,n1([C@@H]2O[C@H](CO)[C@H]([C@@H]2O)O)c(nc(N)cc1)=O,"Cytarabine is associated with a low rate of transient serum enzyme and bilirubin elevations during therapy, but has only rarely been implicated in cases of clinically apparent acute liver injury with jaundice.",-1,CAS 147-94-4,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Decitabine,C1(n2c(=O)nc(nc2)N)OC([C@H](C1)O)CO,"Decitabine is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in causing clinically apparent liver injury with jaundice.",-1,CAS 2353-33-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Docetaxel,O=C(OC(C)(C)C)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@@H]4C(=C3/[C@@H](O)C(=O)[C@]6([C@H]([C@H](OC(=O)c2ccccc2)[C@@](O)(C3(C)C)C4)[C@@]5(OC(=O)C)[C@H](OC5)C[C@@H]6O)C)/C,"Therapy with docetaxel has been associated with a low rate of serum enzyme elevations, but has not been clearly linked to cases of clinically apparent acute liver injury.",-1,CAS 114977-28-5,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Paclitaxel,CC1=C2[C@@]([C@]([C@H]([C@@H]3[C@]4([C@H](OC4)C[C@@H]([C@]3(C(=O)[C@@H]2OC(=O)C)C)O)OC(=O)C)OC(=O)c5ccccc5)(C[C@@H]1OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)O)(C)C,"Therapy with paclitaxel has been associated with a low rate of serum enzyme elevations, but has not been clearly linked to cases of clinically apparent acute liver injury.",-1,CAS 33069-62-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Vincristine,CC[C@@]1(C[C@@H]2C[C@@](c3c(c4ccccc4[nH]3)CC[N@@](C2)C1)(c5cc6c(cc5OC)N([C@@H]7[C@]68CCN9[C@H]8[C@@](C=CC9)([C@H]([C@@]7(C(=O)OC)O)OC(=O)C)CC)C=O)C(=O)OC)O,"Despite their cytotoxic activity against cancer cells, the vinca alkaloids have rarely been implicated in causing clinically apparent acute liver injury.",-1,CAS 57-22-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Everolimus,OCCO[C@@H]1CC[C@H](C[C@H]1OC)C[C@@H](C)[C@@H]4CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N3CCCC[C@H]3C(=O)O4,"Everolimus therapy can be associated with mild serum enzyme elevations, but has yet to be linked to instances of clinically apparent liver injury with jaundice.",-1,CAS 159351-69-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,"Temsirolimus therapy is frequently associated with mild serum enzyme elevations, but has yet to be linked to instances of clinically apparent liver injury with jaundice.",-1,CAS 162635-04-3,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Benztropine,C(c1ccccc1)(c1ccccc1)O[C@H]1CC2N(C(C1)CC2)C,"Benztropine has not been associated with serum enzyme elevations during treatment and must be a very rare cause of clinically apparent acute liver injury, if it occurs at all.",-1,CAS 86-13-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Biperiden,C1(C(CCN2CCCCC2)(O)c2ccccc2)C2CC(C1)C=C2,"Biperiden has not been associated with serum enzyme elevations during treatment and must be a very rare cause of clinically apparent acute liver injury, if it occurs at all.",-1,CAS 514-65-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Pramipexole,c12c(C[C@H](CC2)NCCC)sc(n1)N,"Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment, but has not been implicated in cases of clinically apparent acute liver injury.",-1,CAS 104632-26-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Selegiline,c1(C[C@H]([N@](CC#C)C)C)ccccc1,"Selegiline has been associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",-1,CAS 14611-51-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Rasagiline,C(N[C@H]1c2ccccc2CC1)C#C,"Rasagiline has been associated with a low rate of serum enzyme elevations during treatment, but has not been linked to instances of clinically apparent acute liver injury.",-1,CAS 136236-51-6,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Entacapone,c1(c(c(cc(c1)/C=C(/C(=O)N(CC)CC)C#N)O)O)[N+](=O)[O-],"Entacapone has been associated with a low rate of serum enzyme elevations during treatment, but has yet to be implicated in cases of clinically apparent acute liver injury with jaundice.",-1,CAS 130929-57-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Aripiprazole,c12c(ccc(c1)OCCCCN1CCN(c3c(c(ccc3)Cl)Cl)CC1)CCC(N2)=O,Aripiprazole therapy has not been associated consistently with serum aminotransferase elevations and has yet to be linked to cases of clinically apparent acute liver injury.,-1,CAS 129722-12-9,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ziprasidone,c1(c2c(cccc2)sn1)N1CCN(CCc2cc3c(NC(C3)=O)cc2Cl)CC1.Cl,Use of ziprasidone has not been consistently associated with serum enzyme elevations and has yet to be linked to instances of clinically apparent acute liver injury.,-1,CAS 146939-27-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Lithium,C(=O)([O-])[O-].[Li+].[Li+],"Lithium has been associated with rare instances of mild serum aminotransferase elevations, but has not been convincingly linked to clinically apparent acute liver injury.",-1,CAS 7439-93-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Pimozide,n1(c2c(cccc2)[nH]c1=O)C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,Pimozide therapy has not been associated with serum aminotransferase elevations nor with cases of clinically apparent acute liver injury.,-1,CAS 2062-78-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Capreomycin,C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N,Capreomycin has not been linked to cases of clinically apparent liver disease,-1,CAS 11003-38-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Emtricitabine,c1c(c(nc(=O)n1[C@@H]2CS[C@@H](O2)CO)N)F,"Emtricitabine does not appear to be a significant cause of drug-induced liver injury, but may cause flares of disease in patients with underlying chronic hepatitis B virus (HBV) infection.",-1,CAS 143491-57-0,0,0,0,0,0,0,0,0,1,0,0,0,train,0
Telbivudine,Cc1cn(c(=O)[nH]c1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,Telbivudine does not appear to be a significant cause of drug-induced liver injury but can be associated with flares of the underlying hepatitis B either during therapy or upon withdrawal.,-1,CAS 3424-98-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Elvitegravir,Clc1cccc(c1F)Cc3c(OC)cc2c(C(=O)\C(=C/N2[C@H](CO)C(C)C)C(=O)O)c3,"Therapy with this elvitegravir based regimen is often associated with transient serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",-1,CAS 697761-98-1,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,"Elvitegravir is used largely in a four drug combination with cobicistat, emtricitabine and tenofovir as therapy of HIV infection.  Therapy with this elvitegravir based regimen is often associated with transient serum aminotransferase elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.",-1,CAS 862111-32-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Raltegravir,c1(nc(c(O)c(n1C)=O)C(NCc1ccc(cc1)F)=O)C(NC(c1oc(nn1)C)=O)(C)C,"Raltegravir has not been linked convincingly to serum aminotransferase elevations during therapy or to episodes of acute, clinically apparent liver injury.",-1,CAS 871038-72-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Entecavir,C=C1[C@H](C[C@@H]([C@H]1CO)O)n2cnc3c2nc([nH]c3=O)N,Entecavir therapy can be associated with flares of the underlying hepatitis B during or after therapy but has not been linked to cases of clinically apparent liver injury.,-1,CAS 142217-69-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ribavirin,n1([C@@H]2O[C@H](CO)[C@H]([C@H]2O)O)nc(C(N)=O)nc1,Ribavirin has not been associated with clinically apparent liver injury.,-1,CAS 36791-04-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Cidofovir,n1(C[C@H](OCP(O)(O)=O)CO)c(nc(N)cc1)=O,Cidofovir has been associated with mild-to-moderate serum aminotransferase elevations during intravenous therapy but has not been convincingly linked to cases of clinically apparent acute liver injury.,-1,CAS 113852-37-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Famciclovir,c12n(cnc1cnc(n2)N)CCC(COC(C)=O)COC(C)=O,Famciclovir is associated with a low rate of mild-to-moderate serum ALT elevations during therapy but has not been associated with instances of clinically apparent liver injury.,-1,CAS 104227-87-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Foscarnet,P(C(=O)O)(O)(O)=O,Foscarnet has been associated with mild-to-moderate serum aminotransferase elevations during intravenous therapy but not with episodes of clinically apparent liver injury.,-1,CAS 63585-09-1,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Ganciclovir,c1nc2c(=O)[nH]c(nc2n1COC(CO)CO)N,"When given intravenously, ganciclovir can cause mild, transient and asymptomatic elevations in serum aminotransferase levels, but neither ganciclovir nor valganciclovir have been associated with clinically apparent liver injury.",-1,CAS 82410-32-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Valganciclovir,n1c([nH]c2n(CO[C@@H](COC([C@H](C(C)C)N)=O)CO)cnc2c1=O)N,"When given intravenously, ganciclovir can cause mild, transient and asymptomatic elevations in serum aminotransferase levels, but neither ganciclovir nor valganciclovir have been associated with clinically apparent liver injury.",-1,CAS 175865-60-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Oseltamivir,O=C(OCC)/C1=C/[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1,Oseltamivir has not been associated with clinically apparent liver injury.,-1,CAS 204255-11-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Rimantadine,NC(C)C13CC2CC(CC(C1)C2)C3,Rimantadine has not been associated with clinically apparent liver injury.,-1,CAS 13392-28-4,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Zanamivir,C1=C(O[C@H]([C@@H]([C@H]1NC(=N)N)NC(=O)C)[C@H]([C@H](CO)O)O)C(=O)O,Zanamivir has not been associated with clinically apparent liver injury.,-1,CAS 139110-80-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Modafinil,C(c1ccccc1)(c1ccccc1)[S@@](CC(N)=O)=O,"Both modafinil and armodafinil are associated with a low rate of serum aminotransferase elevations during therapy, but they have not been implicated in cases of clinically apparent acute liver injury.",-1,CAS 68693-11-8,0,0,0,0,0,1,0,0,0,0,0,0,test,0
Aztreonam,[C@@H]1([C@@H](N(C1=O)S(=O)(=O)[O-])C)NC(=O)/C(=N\OC(C(=O)O)(C)C)c1csc(n1)[NH2+],"Aztreonam therapy is often accompanied by mild, asymptomatic elevations in serum aminotransferase levels, but it has not been reported to cause clinically apparent liver injury.",-1,CAS 78110-38-0,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Baclofen,c1cc(ccc1C(CC(=O)O)CN)Cl,Baclofen has not been convincingly linked to clinically significant liver injury.,-1,CAS 1134-47-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Diazepam,C1(=NCC(=O)N(c2c1cc(cc2)Cl)C)c1ccccc1,"Diazepam therapy has not been associated with serum aminotransferase elevations, and clinically apparent liver injury from diazepam has been reported but is exceedingly rare.",-1,CAS 439-14-5,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Estazolam,c12c(C(c3ccccc3)=NCc3n1cnn3)cc(Cl)cc2,"As with most benzodiazepines, estazolam therapy has not associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from estazolam has not been reported and must be very rare if it occurs at all.",-1,CAS 29975-16-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Lorazepam,C1(=NC(C(=O)Nc2c1cc(cc2)Cl)O)c1ccccc1Cl,"As with most benzodiazepines, lorazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from lorazepam has not been reported and must be very rare if it occurs at all.",-1,CAS 846-49-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Midazolam,c12c(C(=NCc3n1c(nc3)C)c1c(cccc1)F)cc(cc2)Cl,Midazolam therapy has not been associated with serum aminotransferase elevations and has not been linked to cases of clinically apparent liver injury.,-1,CAS 59467-70-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Oxazepam,c12C(c3ccccc3)=N[C@@H](O)C(Nc1ccc(c2)Cl)=O,"As with most benzodiazepines, oxazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from oxazepam has not been reported and must be very rare if it occurs at all.",-1,CAS 604-75-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Quazepam,c12c(C(c3c(cccc3)F)=NCC(N1CC(F)(F)F)=S)cc(Cl)cc2,"As with most benzodiazepines, quazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from quazepam has not been reported and must be very rare if it occurs at all.",-1,CAS 36735-22-5,0,0,0,0,0,0,0,0,1,0,0,0,train,0
Temazepam,c12C(=NC(C(=O)N(c1ccc(c2)Cl)C)O)c1ccccc1,"As with most benzodiazepines, temazepam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from temazepam has not been reported and must be very rare if it occurs at all.",-1,CAS 846-50-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Buprenorphine,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CC[N@]([C@@H]3Cc6c5c(c(cc6)O)O4)CC7CC7)OC)(C(C)(C)C)O,"Therapy with buprenorphine has not been associated with serum enzyme elevations, and clinically apparent liver injury has been reported largely with overdose and abuse (intravenous administration of the sublingual formulation).",-1,CAS 52485-79-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,"Despite wide scale use, it is an infrequent cause of serum enzyme elevations and has not been linked to instances of clinically apparent liver injury with jaundice.",-1,CAS 36505-84-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Carisoprodol,C(N)(=O)OC[C@@](COC(NC(C)C)=O)(CCC)C,Carisoprodol is a centrally acting muscle relaxant has been in use for more than fifty years without significant evidence for causing hepatic injury.,-1,CAS 78-44-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Cefuroxime,N12[C@@H]([C@@H](NC(\C(c3ccco3)=N/OC)=O)C2=O)SCC(=C1C(O)=O)COC(N)=O,"Despite their wide-scale use, cases of drug induced liver disease from the cephalosporins are very rare, with only isolated case reports having been published.",-1,CAS 55268-75-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Cefazolin,Cc1nnc(s1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)Cn4cnnn4)SC2)C(=O)[O-].[Na+],"Despite their wide-scale use, cases of drug induced liver disease from the cephalosporins are very rare; only isolated case reports having been published.",-1,CAS 25953-19-9,0,0,0,0,0,0,1,0,0,0,0,0,train,0
Chloral hydrate,C(C(Cl)(Cl)Cl)(O)O,"Despite many years of use, chloral hydrate has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.",-1,CAS 302-17-0,0,0,0,0,0,0,0,0,1,0,0,0,test,0
Glucosamine,O1[C@@H]([C@@H]([C@@H]([C@H](N)[C@H]1O)O)O)CO,"Glucosamine has been implicated in isolated case reports in causing clinically apparent liver injury, but the role of glucosamine as opposed to other herbal components or contaminants has not been shown and liver injury due to glucosamine or chondroitin must be very rare if it occurs at all.",-1,CAS 3416-24-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Chondroitin,O([C@@H]1[C@H]([C@@H](O[C@@H]([C@@H]1O)OS(O)(=O)=O)O)NC(C)=O)[C@@H]1O[C@@H]([C@@H](O)[C@@H]([C@H]1O)O)C(O)=O,"Glucosamine has been implicated in isolated case reports in causing clinically apparent liver injury, but the role of glucosamine as opposed to other herbal components or contaminants has not been shown and liver injury due to glucosamine or chondroitin must be very rare if it occurs at all.",-1,CAS 9007-28-7,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Cyclobenzaprine,C1(=C\CCN(C)C)/c2c(C=Cc3c1cccc3)cccc2,"Despite its similarity to tricyclic antidepressants, there is little evidence that cyclobenzaprine causes liver injury.",-1,CAS 303-53-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Diethylpropion,c1(C([C@@H](N(CC)CC)C)=O)ccccc1,Diethylpropion has not been linked to either serum enzyme elevations or to clinically apparent acute liver injury.,-1,CAS 134-80-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Dihydroergotamine,N12[C@@]([C@H]3N(CCC3)C([C@@H]1Cc1ccccc1)=O)(O[C@](NC([C@@H]1C[C@@H]3c4c5c(c[nH]c5ccc4)C[C@H]3[N@@](C1)C)=O)(C)C2=O)O,Ergot alkaloids have multiple side effects but have little effect on the liver and have not been clearly linked to instances of clinically apparent acute liver injury.,-1,CAS 6190-39-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ergotamine,[nH]1c2c3c(c1)C[C@@H]1C(c3ccc2)=C[C@H](C[N@@]1C)C(=O)N[C@]1(C(N2[C@@]([C@H]3N(C([C@@H]2Cc2ccccc2)=O)CCC3)(O1)O)=O)C,Ergot alkaloids have multiple side effects but have little effect on the liver and have not been clearly linked to instances of clinically apparent acute liver injury.,-1,CAS 113-15-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Eplerenone,COC(=O)[C@@H]4C\C1=C\C(=O)CC[C@]1(C)[C@@]65O[C@@H]6C[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45,"Eplerenone therapy has been associated with transient elevations in serum aminotransferase levels, but has yet to be linked to cases of clinically apparent drug-induced liver disease.",-1,CAS 107724-20-9,1,0,0,0,0,0,0,0,0,0,0,0,train,0
Vardenafil,C1CN(CCN1CC)S(=O)(=O)c1cc(c(cc1)OCC)c1[nH]n2c(c(=O)n1)c(nc2CCC)C,Vardenafil has not been associated with serum aminotransferase elevations nor with clinically apparent liver injury.,-1,CAS 224785-90-4,0,0,0,1,0,0,0,0,0,0,0,0,train,0
Eszopiclone,CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,Eszopiclone has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.,-1,CAS 138729-47-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Yohimbine,c12[C@H]3[N@@](C[C@@H]4CC[C@@H]([C@@H]([C@@H]4C3)C(OC)=O)O)CCc1c1ccccc1[nH]2,"Yohimbine use has been associated with occasional severe adverse events, but has not been linked to serum enzyme elevations or clinically apparent acute liver injury.",-1,CAS 146-48-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Resveratrol,C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O,Resveratrol use has not been associated with serum enzyme elevations or with clinically apparent liver injury.,-1,CAS 501-36-0,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Isotretinoin,C=1(C(CCCC1C)(C)C)\C=C\C(=C\C=C\C(=C/C(O)=O)C)C,"Isotretinoin, like many retinoids, can lead to increase in serum aminotransferase levels, but, unlike acitretin and etretinate, isotretinoin has not been clearly implicated in cases of clinically apparent acute liver injury with jaundice.",-1,CAS 4759-48-2,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ketorolac,n12c([C@@H](C(O)=O)CC2)ccc1C(c1ccccc1)=O,"Ketorolac is generally given for a few days only, and has not been linked to instances of idiosyncratic drug-induced liver disease in the published literature.",-1,CAS 66635-83-4,0,0,0,0,0,0,0,1,0,0,0,0,train,0
Melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Melatonin has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.,-1,CAS 73-31-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Meprobamate,O=C(OCC(COC(=O)N)(C)CCC)N,"Meprobamate is a sedative used for anxiety and insomnia, which infrequently causes liver enzyme elevations and which has not been linked to instances of clinically apparent liver injury.",-1,CAS 57-53-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Metaxalone,Cc1cc(cc(c1)OCC2CNC(=O)O2)C,Metaxalone has not been associated with serum aminotransferase elevations during therapy or with clinically apparent hepatic injury.,-1,CAS 1665-48-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Methocarbamol,COc1ccccc1OCC(COC(=O)N)O,"Methocarbamol is a commonly used, centrally acting muscle relaxant and has not been linked to instances of liver injury.",-1,CAS 532-03-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Orphenadrine,c1([C@@H](c2ccccc2)OCCN(C)C)c(cccc1)C,Orphenadrine is a centrally acting muscle relaxant that has been in clinical use for more than 50 years and has not been linked to liver injury or clinically apparent drug-induced liver disease.,-1,CAS 83-98-7,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Nicotine,[C@H]1(c2cccnc2)N(CCC1)C,Nicotine has not been associated with liver test abnormalities or with clinically apparent hepatotoxicity.,-1,CAS 54-11-5,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Benzylpenicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)Cc3ccccc3)C(=O)O)C,Penicillin G and V are first-generation penicillins that are used widely to treat infections due to susceptible organisms and have been linked rarely and only weakly with idiosyncratic liver injury.,-1,CAS 1110-47-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Penicillin V,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COc3ccccc3)C(=O)O)C,Penicillin G and V are first-generation penicillins that are used widely to treat infections due to susceptible organisms and have been linked rarely and only weakly with idiosyncratic liver injury.,-1,CAS 87-08-1,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Phentermine,NC(Cc1ccccc1)(C)C,Phentermine is a sympathomimetic amine and anorectic agent used for the short-term therapy of obesity. Phentermine has not been linked to either serum enzyme elevations or to clinically apparent acute liver injury.,-1,CAS 122-09-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Ramelteon,O=C(NCC[C@@H]3c2c(ccc1OCCc12)CC3)CC,Ramelteon has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.,-1,CAS 196597-26-9,0,0,0,0,0,0,0,0,0,0,0,0,test,0
Rifaximin,C1=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](C=CC=C(C(Nc2c3c(nc4cc(C)ccn34)c3c(c2O)c(O)c(c2c3C([C@@](O2)(O1)C)=O)C)=O)C)C)O)C)O)C)OC(C)=O)C)OC,Rifaximin has minimal oral absorption and has not been implicated in causing liver test abnormalities or clinically apparent liver injury.,-1,CAS 80621-81-4,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,Zaleplon has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.,-1,CAS 151319-34-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Zolpidem has rarely been implicated in causing serum enzyme elevations and has not been reported to cause clinically apparent liver injury.,-1,CAS 82626-48-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Sibutramine,ClC1=CC=C(C2(CCC2)C(CC(C)C)N(C)C)C=C1,"In large clinical trials, sibutramine therapy was not associated with serum enzyme elevations, and it has only rarely been implicated in cases of clinically apparent, acute liver injury.",-1,CAS 106650-56-0,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Tetracycline,C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O.Cl,High doses of several forms of tetracycline given intravenously have been associated with acute fatty liver that can be severe and result in liver failure and death. Oral tetracycline use has been rarely and not very convincingly linked to acute hepatic injury.,-1,CAS 60-54-8,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Tigecycline,CC(C)(C)NCC(=O)Nc1cc(c2c(c1O)C(=O)C3=C([C@]4([C@@H](C[C@@H]3C2)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)N(C)C,"Tigecycline therapy is sometimes accompanied by minor aminotransferase elevations, but has not been definitely associated with clinically apparent liver injury with jaundice.",-1,CAS 220620-09-7,0,0,0,0,0,0,0,0,0,0,1,0,train,0
Tramadol,c1([C@@]2([C@H](CCCC2)CN(C)C)O)cc(ccc1)OC,Tramadol overdose can cause acute liver failure. Pharmacologic use of tramadol has not been associated with cases of clinically apparent drug-induced liver disease.,-1,CAS 27203-92-5,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Vancomycin,c12c3c(cc(O)cc3O)[C@H](NC(=O)[C@H]3NC(=O)[C@H](NC(=O)[C@H]4c5cc(Oc6c(Cl)cc([C@H]3O)cc6)c(O[C@H]3[C@H](O[C@@H]6O[C@@H](C)[C@@H](O)[C@](N)(C)C6)[C@@H](O)[C@H](O)[C@@H](CO)O3)c(Oc3c(Cl)cc([C@@H](O)[C@H](C(=O)N[C@@H](CC(=O)N)C(=O)N4)NC(=O)[C@@H](CC(C)C)NC)cc3)c5)c(ccc1O)c2)C(=O)O,"Vancomycin therapy has been linked many to instances of hypersensitivity with fever, rash and eosinophilia that can be associated with mild hepatic injury, but despite over 50 years of use, it has not been linked to cases of serious hepatotoxicity.",-1,CAS 1404-90-6,0,0,0,0,0,0,0,0,0,0,0,0,train,0
Acarbose ,O([C@@H]1[C@@H]([C@H]([C@H](N[C@H]2C=C([C@@H](O)[C@@H]([C@H]2O)O)CO)[C@H](O1)C)O)O)[C@H]1[C@@H]([C@@H](O)[C@H](O[C@@H]1CO)O[C@@H]1[C@H](O[C@@H](O)[C@@H]([C@H]1O)O)CO)O,Acarbose has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 56180-94-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Benazepril,c12ccccc2CC[C@@H](C(N1CC(O)=O)=O)N[C@@H](CCc1ccccc1)C(OCC)=O,Benazepril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 86541-75-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Captopril,N1([C@@H](CCC1)C(O)=O)C([C@@H](CS)C)=O,Captopril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 62571-86-2,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Enalapril,N1([C@@H](CCC1)C(O)=O)C([C@@H](N[C@H](CCc1ccccc1)C(OCC)=O)C)=O,Enalapril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 75847-73-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Fosinopril,C1[C@H](C2CCCCC2)C[C@H](C(O)=O)N1C(C[P@@](O[C@@H](OC(CC)=O)C(C)C)(CCCCc1ccccc1)=O)=O,Fosinopril is associated with a low rate of transient serum aminotransferase elevations during therapy and has been linked to rare instances of acute liver injury.,0,CAS 98048-97-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Perindopril,N1([C@@H]2[C@@H](CCCC2)C[C@H]1C(O)=O)C([C@H](N[C@H](C(OCC)=O)CCC)C)=O,Perindopril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 107133-36-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ramipril,N1([C@@H]2[C@@H](CCC2)C[C@H]1C(O)=O)C([C@@H](N[C@@H](CCc1ccccc1)C(OCC)=O)C)=O,Ramipril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 87333-19-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Acebutolol,c1(c(cc(cc1)NC(=O)CCC)C(=O)C)OCC(CNC(C)C)O,Acebutolol has been linked to several instances of clinically apparent drug-induced liver injury.,0,CAS 37517-30-9,0,0,0,0,0,0,0,0,0,0,1,0,train,1
Acetaminophen,c1(ccc(cc1)O)NC(=O)C,"Harmless at low doses, acetaminophen has direct hepatotoxic potential when taken as an overdose and can cause acute liver injury and death from acute liver failure. ",0,CAS 103-90-2,0,0,0,0,0,0,0,0,0,0,1,0,train,1
Acetazolamide,O=S(=O)(c1nnc(s1)NC(=O)C)N,Both acetazolamide and methazolamide have been linked to rare cases of clinically apparent drug-induced liver disease.,0,CAS 59-66-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Albendazole,c12c(nc([nH]1)NC(=O)OC)cc(cc2)SCCC,Albendazole therapy is commonly associated with mild and transient serum enzyme elevations and rarely can lead to clinically apparent acute liver injury.,0,CAS 54965-21-8,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Alendronate,P([C@@](P(O)(=O)[O-])(CCCN)O)(O)(O)=O.[Na+].O.O.O,Therapy with the bisphosphonates has been associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent liver injury.,0,CAS 66376-36-1,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Etidronate,O=P(O)(O)C(O)(C)P(=O)(O)O,Therapy with the bisphosphonates has been associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent liver injury.,0,CAS 100511-44-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ibandronate,CCCCC[N@@](C)CCC(O)(P(O)(=O)O)P(O)(=O)O,Therapy with the bisphosphonates has been associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent liver injury.,0,CAS 114084-78-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Pamidronate,C(P(O)(O)=O)(P(O)(O)=O)(CCN)O,Therapy with the bisphosphonates has been associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent liver injury.,0,CAS 40391-99-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Risedronate,OP(=O)(C(P(=O)(O)O)(Cc1cnccc1)O)O,Therapy with the bisphosphonates has been associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent liver injury.,0,CAS 105462-24-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Zoledronic Acid,c1cncn1CC(O)(P(O)(=O)O)P(O)(=O)O,Therapy with the bisphosphonates has been associated with a low rate of serum enzyme elevations during therapy and has been linked to rare instances of clinically apparent liver injury.,0,CAS 118072-93-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Alfuzosin,CN(CCCNC(=O)C1CCCO1)c2nc3cc(c(cc3c(n2)N)OC)OC,Alfuzosin is associated with a low rate of transient serum aminotransferase elevations with rare instances of clinically apparent acute liver injury.,0,CAS 81403-80-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Altretamine,c1(nc(nc(n1)N(C)C)N(C)C)N(C)C,"Altretamine therapy has been associated with low rates of serum enzyme elevations during therapy and with rare instances of acute, clinically apparent injury.",0,CAS 645-05-6,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Chlorambucil,c1(N(CCCl)CCCl)ccc(cc1)CCCC(O)=O,"Chlorambucil therapy has been associated with low rates of serum enzyme elevations during therapy and to rare instances of acute, clinically apparent injury.",0,CAS 305-03-3,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Cyclophosphamide,N(CCCl)(CCCl)[P@@]1(OCCCN1)=O.O,Cyclophosphamide therapy is associated with minor transient serum enzyme elevations and has been linked to rare cases of acute liver injury.,0,CAS 6055-19-2,0,0,0,0,0,0,0,0,1,0,0,0,test,1
Lomustine,C1(NC(=O)N(CCCl)N=O)CCCCC1,Lomustine therapy is associated with minor transient serum enzyme elevations and has been linked to rare cases of clinically apparent acute liver injury.,0,CAS 13010-47-4,0,1,0,0,0,0,0,0,1,0,0,0,test,1
Melphalan,c1(N(CCCl)CCCl)ccc(C[C@@H](C(=O)O)N)cc1,"Melphalan therapy has been associated with low rates of serum enzyme elevations during therapy, but when used in high doses as myeloablative therapy in preparation for hematopoietic cell transplantation, it is associated with high rates of enzyme elevations and acute liver injury due to sinusoidal obstruction syndrome.",0,CAS 148-82-3,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Procarbazine,c1(C(NC(C)C)=O)ccc(CNNC)cc1,"Procarbazine therapy has been associated with serum enzyme elevations during therapy and with rare cases of idiosyncratic, clinically apparent acute liver injury.",0,CAS 671-16-9,0,1,0,0,0,0,0,0,0,0,0,0,test,1
Thiotepa,P(=S)(N1CC1)(N1CC1)N1CC1,"Thiotepa therapy has been associated with low rates of serum enzyme elevations during therapy and very rare instances of acute, clinically apparent injury.",0,CAS 52-24-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Almotriptan,c1c(cc2c(c[nH]c2c1)CCN(C)C)CS(N1CCCC1)(=O)=O,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 181183-52-8,0,0,0,1,0,0,0,0,0,0,0,0,train,1
Eletriptan,CN1CCC[C@@H]1Cc2c[nH]c3c2cc(cc3)CCS(=O)(=O)c4ccccc4.Br,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 143322-58-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Frovatriptan,CN[C@@H]1CCc2c(c3cc(ccc3[nH]2)C(=O)N)C1,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 158747-02-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Naratriptan,c12c(C3CCN(C)CC3)c[nH]c1ccc(c2)CCS(NC)(=O)=O,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 121679-13-8,0,0,0,1,0,0,0,0,0,0,0,0,test,1
Rizatriptan,[nH]1cc(c2cc(ccc12)Cn1ncnc1)CCN(C)C,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 145202-66-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Sumatriptan,CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CCN(C)C,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 103628-46-2,0,0,0,1,0,0,0,0,0,0,0,0,test,1
Zolmitriptan,c12c([nH]cc1CCN(C)C)ccc(c2)C[C@@H]1NC(=O)OC1,"The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.",0,CAS 139264-17-8,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Terazosin,COc1cc2c(cc1OC)nc(nc2N)N3CCN(CC3)C(=O)C4CCCO4,Terazosin therapy is associated with a low rate of transient serum aminotransferase elevations and to rare instances of clinically apparent acute liver injury.,0,CAS 63590-64-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 73-48-3,0,0,0,1,0,0,0,0,1,0,0,0,test,1
Chlorothiazide,O=S(c1cc(S(=O)(NC=N2)=O)c2cc1Cl)(N)=O,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 58-94-6,0,0,0,1,0,0,0,0,0,0,0,0,test,1
Chlorthalidone,O=S(=O)(N)c1c(Cl)ccc(c1)C2(O)c3ccccc3C(=O)N2,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 77-36-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Hydrochlorothiazide,c12c(cc(c(c1)S(=O)(=O)N)Cl)NCNS2(=O)=O,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 58-93-5,0,0,0,1,0,0,0,0,0,0,0,0,train,1
Indapamide,c12N(C(Cc1cccc2)C)NC(=O)c1cc(c(cc1)Cl)S(=O)(=O)N,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 26807-65-8,0,1,0,0,0,0,0,0,0,0,0,0,test,1
Methyclothiazide,c12c(cc(S(N)(=O)=O)c(c2)Cl)S([N@@](C)[C@@H](N1)CCl)(=O)=O,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 135-07-9,0,0,0,1,0,0,0,0,1,0,0,0,train,1
Metolazone,c12c(N[C@@H](C)N(C1=O)c1c(cccc1)C)cc(Cl)c(c2)S(N)(=O)=O,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 17560-51-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Polythiazide,c12c(cc(S(N)(=O)=O)c(c2)Cl)S([N@@](C)[C@@H](N1)CSCC(F)(F)F)(=O)=O,Only rare instances of clinically apparent liver injury have been linked to use of thiazide diuretics.,0,CAS 346-18-9,0,0,0,1,0,0,1,0,1,0,0,0,train,1
Amiloride,c1(nc(c(nc1N)N)C(NC(N)=N)=O)Cl,Amiloride has been linked to rare cases of clinically apparent drug-induced liver disease.,0,CAS 2016-88-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Atenolol,c1(ccc(cc1)CC(=O)N)OCC(CNC(C)C)O,Atenolol has been linked to rare cases of drug-induced liver injury.,0,CAS 29122-68-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Carvedilol,c12c3c(cccc3)[nH]c1cccc2OC[C@@H](CNCCOc1c(cccc1)OC)O,Carvedilol has been linked to at least one instance of clinically apparent liver injury.,0,CAS 72956-09-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,Metoprolol has been linked to rare cases of drug-induced liver injury.,0,CAS 37350-58-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Sotalol,CC(C)NCC(c1ccc(cc1)NS(=O)(=O)C)O,Sotalol has been linked to at least one instance of clinically apparent liver injury.,0,CAS 3930-20-9,0,0,0,1,0,0,0,0,0,0,0,0,train,1
Candesartan,CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5)C(=O)O,Candesartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 139481-59-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5,Irbesartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 138402-11-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,Losartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 114798-26-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Valsartan,CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[nH]nnn3)[C@@H](C(C)C)C(=O)O,Valsartan is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury.,0,CAS 137862-53-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Amlodipine,CCOC(=O)C1=C(NC(=C(C1c2ccccc2Cl)C(=O)OC)C)COCCN,Amlodipine has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.,0,CAS 88150-42-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Nimodipine ,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,Nimodipine is not widely used and has not been implicated in causing clinically apparent acute liver injury.,0,CAS 66085-59-4,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Diltiazem,c1cc2S[C@H]([C@@H](OC(C)=O)C(N(c2cc1)CCN(C)C)=O)c1ccc(cc1)OC,Diltiazem therapy is associated with serum enzyme elevations and has been linked to rare instances of clinically apparent liver injury.,0,CAS 42399-41-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)c2ccccc2[N+](=O)[O-])C(=O)OC,Nifedipine therapy is associated with a low rate of serum enzyme elevations and has been linked to several instances of clinically apparent acute liver injury.,0,CAS 21829-25-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Verapamil,c1([C@@](CCC[N@@](CCc2cc(c(OC)cc2)OC)C)(C(C)C)C#N)cc(c(OC)cc1)OC,Verapamil has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury. ,0,CAS 52-53-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Silodosin,C(O)CCN1c2c(cc(C[C@H](NCCOc3c(cccc3)OCC(F)(F)F)C)cc2CC1)C(=O)N,Silodosin is associated with a low rate of serum aminotransferase elevations and to rare instances of clinically apparent acute liver injury.,0,CAS 160970-54-7,0,0,0,0,0,0,0,0,1,0,0,0,test,1
Tamsulosin,c1(c(ccc(c1)C[C@H](NCCOc1c(cccc1)OCC)C)OC)S(N)(=O)=O,Tamsulosin therapy is associated with a low rate of serum aminotransferase elevations but clinically apparent acute liver injury due to tamsulosin is very rare.,0,CAS 106133-20-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Alprazolam,c12c(C(c3ccccc3)=NCc3n1c(nn3)C)cc(Cl)cc2,"alprazolam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from alprazolam has been reported but is very rare.",0,CAS 28981-97-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Donepezil,N1(CCC(CC2C(=O)c3cc(c(cc3C2)OC)OC)CC1)Cc1ccccc1,Donepezil is associated with a minimal rate of serum enzyme elevations during therapy and has only rarely been implicated as a cause of clinically apparent liver injury.,0,CAS 120014-06-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Memantine,C1[C@@]2(CC3(CC(C2)C[C@@]1(C3)C)N)C,Memantine is associated with a minimal rate of serum enzyme elevations during therapy and has only rarely been implicated as a cause of clinically apparent acute liver injury.,0,CAS 19982-08-2,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Tacrine,c12c(c(c3c(n1)CCCC3)N)cccc2,"Tacrine therapy is associated with a very high rate of serum aminotransferase elevations during therapy and has been linked to several instances of clinically apparent, acute liver injury.",0,CAS 321-64-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Amoxicillin,N12[C@@H]([C@@H](C2=O)NC(=O)[C@@H](c2ccc(cc2)O)N)SC([C@@H]1C(=O)O)(C)C,"Amoxicillin and other aminopenicillins have been linked with idiosyncratic liver injury, but only rarely and in isolated case reports.",0,CAS 26787-78-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ampicillin,N([C@H]1[C@@H]2N(C1=O)[C@H](C(C)(C)S2)C(=O)O)C([C@@H](c1ccccc1)N)=O,Ampicillin has been linked with idiosyncratic liver injury but very rarely and in isolated case reports.,0,CAS 69-53-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Amphetamine,c1(ccccc1)CC(N)C,"there have been several case reports of clinically apparent acute liver injury attributed to the amphetamines, particularly when used intravenously.",0,CAS 300-62-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Anastrozole,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,Anastrozole has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.,0,CAS 120511-73-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Desflurane,C(C(F)(F)F)(OC(F)F)F,Rare single case reports of severe acute liver injury resembling halothane hepatitis due to desflurane have been published.,0,CAS 57041-67-5,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,Sevoflurane has been implicated in rare single case reports of severe acute liver injury similar to halothane hepatitis.,0,CAS 28523-86-6,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Propofol,c1(c(c(C(C)C)ccc1)O)C(C)C,Propofol has been associated with rare instances of idiosyncratic acute liver injury;,0,CAS 2078-54-8,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Bicalutamide,c1(c(ccc(c1)NC([C@@](CS(c1ccc(F)cc1)(=O)=O)(C)O)=O)C#N)C(F)(F)F,Bicalutamide is a nonsteroidal antiandrogen similar in structure to flutamide that is used widely in the therapy of prostate cancer and has been linked to rare instances of liver injury.,0,CAS 90357-06-5,0,0,0,0,0,0,0,0,1,0,0,0,test,1
Nilutamide,CC1(C(=O)N(C(=O)N1)c2ccc(c(c2)C(F)(F)F)[N+](=O)[O-])C,Nilutamide is an oral nonsteroidal antiandrogen similar in structure to flutamide that is used widely in the therapy of prostate cancer and has been linked to rare instances of liver injury.,0,CAS 63612-50-0,0,0,0,0,0,0,0,0,1,0,0,0,test,1
Propafenone,c1(c(C(CCc2ccccc2)=O)cccc1)OC[C@@H](CNCCC)O,"Long term propafenone therapy is associated with a low rate of serum aminotransferase elevations and therapy rarely can cause a self limited, acute cholestatic liver injury.",0,CAS 54063-53-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury.,0,CAS 158966-92-8,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Zileuton,c1([C@@H](N(C(N)=O)O)C)cc2ccccc2s1,Zileuton has been linked to several cases of drug induced liver disease and is considered to be contraindicated in patients with active liver disease.,0,CAS 111406-87-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ticlopidine,c12c(CCN(C1)Cc1c(cccc1)Cl)scc2,"Ticlopidine is associated with a low rate of serum enzyme elevations during treatment and has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury.",0,CAS 55142-85-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Clopidogrel,C1[N@@]([C@@H](C(=O)OC)c2ccccc2Cl)Cc2c(C1)scc2,"Clopidogrel has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury.",0,CAS 113665-84-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Dabigatran,CCCCCCOC(=O)N=C(N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=CC=CC=N3)N2C)C=C1,Dabigatran therapy has been associated with a low rate of serum enzyme elevations and rare instances of liver enzyme elevations and jaundice.,0,CAS 211915-06-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C=CC=C2,"Warfarin therapy is associated with rare instances of idiosyncratic, clinically apparent liver injury that are usually mild and rapidly reversible on stopping.",0,CAS 81-81-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Clorazepate,C1(=NC(C(=O)Nc2c1cc(cc2)Cl)C(=O)[O-])c1ccccc1.O[K].[K+],"Therapy with clorazepate is not associated with serum aminotransferase elevations, and cases of clinically apparent liver injury from clorazepate have been reported but are very rare.",0,CAS 23887-31-2,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Gabapentin,C1CCC(CC1)(CC(=O)O)CN,"Therapy with gabapentin is not associated with serum aminotransferase elevations, and clinically apparent liver injury from gabapentin is very rare.",0,CAS 60142-96-3,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Levetiracetam,N1([C@H](C(=O)N)CC)C(=O)CCC1,Levetiracetam has been linked to rare instances of serum aminotransferase and alkaline phosphatase elevations during treatment and to rare cases of clinically apparent drug induced liver disease.,0,CAS 102767-28-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Oxcarbazepine,c12N(c3c(cccc3)CC(c1cccc2)=O)C(N)=O,Oxcarbazepine has been linked to rare instances of clinically apparent acute drug induced liver injury which resembles carbamazepine hepatotoxicity.,0,CAS 28721-07-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Pregabalin,C([C@@H](CC(C)C)CC(O)=O)N,"Therapy with pregabalin is not associated with serum aminotransferase elevations, and clinically apparent liver injury from pregabalin has been reported but appears to be quite rare.",0,CAS 148553-50-8,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Topiramate,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,Topiramate has been rarely associated with hepatic injury and largely when used in combination with other anticonvulsant medications.,0,CAS 97240-79-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Zonisamide,c12c(noc1cccc2)CS(N)(=O)=O,Zonisamide has not been associated with elevations in serum aminotransferase levels and clinically apparent drug induced liver disease has been reported with its use but is very rare.,0,CAS 68291-97-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Isocarboxazid,c1(onc(c1)C(NNCc1ccccc1)=O)C,Isocarboxazid therapy is associated with rare instances of clinically apparent acute liver injury.,0,CAS 59-63-2,0,1,0,0,0,0,0,0,0,0,0,0,test,1
Phenelzine,c1(ccccc1)CCNN,Phenelzine therapy is associated with rare instances of clinically apparent acute liver injury.,0,CAS 51-71-8,0,1,0,0,0,0,0,0,0,0,0,0,train,1
Tranylcypromine,c1ccccc1[C@H]1[C@@H](N)C1,Tranylcypromine therapy is associated with rare instances of clinically apparent acute liver injury.,0,CAS 155-09-9,0,0,0,0,0,0,0,0,0,1,0,0,train,1
Bupropion,CC(C(=O)c1cccc(c1)Cl)NC(C)(C)C,"Bupropion therapy can be associated with transient, usually asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.",0,CAS 34841-39-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Mirtazapine,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 61337-67-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Citalopram,c12[C@@](c3ccc(F)cc3)(OCc1cc(C#N)cc2)CCCN(C)C,Citalopram have been associated with rare instances of clinically apparent acute liver injury.,0,CAS 59729-33-8,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Duloxetine,s1cccc1[C@@H](Oc1cccc2c1cccc2)CCNC,Duloxetine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 136434-34-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Fluoxetine,c1([C@@H](Oc2ccc(C(F)(F)F)cc2)CCNC)ccccc1,Fluoxetine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 54910-89-3,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Fluvoxamine,c1(\C(CCCCOC)=N\OCCN)ccc(C(F)(F)F)cc1,Fluvoxamine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 54739-18-3,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Paroxetine,c1([C@H]2[C@H](COc3cc4c(OCO4)cc3)CNCC2)ccc(F)cc1,Paroxetine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 61869-08-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Sertraline,CN[C@H]1CC[C@H](c2c1cccc2)c3ccc(c(c3)Cl)Cl,Sertraline therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 79617-96-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Venlafaxine,C1CCCC(C1)([C@@H](c1ccc(cc1)OC)CN(C)C)O,Venlafaxine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 93413-69-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Protriptyline,c3cc2c(\C=C/c1c(cccc1)C2CCCNC)cc3,"The potential hepatotoxicity specifically of protriptyline, however, has not been well defined.",0,CAS 438-60-8,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Linagliptin,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,Linagliptin has been linked to rare instances of clinically apparent liver injury.,0,CAS 668270-12-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Saxagliptin,O=C(N1[C@H](C#N)C[C@@H]2C[C@H]12)[C@@H](N)C35CC4CC(C3)CC(O)(C4)C5,Saxagliptin is a relatively new medication and has yet to be implicated in causing clinically apparent liver injury.,0,CAS 361442-04-8,0,0,0,0,0,0,0,0,0,1,0,0,train,1
Sitagliptin,c1(c(F)cc(c(F)c1)C[C@H](CC(N1CCn2c(C1)nnc2C(F)(F)F)=O)N)F,Only rare isolated reports of liver injury due to sitagliptin have been published.,0,CAS 486460-32-6,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Metformin,C(=N)(NC(=N)N)N(C)C,Metformin has not been linked to serum enzyme elevations during therapy and is an exceeding rare cause of idiosyncratic clinically apparent acute liver injury.,0,CAS 657-24-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Nateglinide,C([C@@H]1CC[C@@H](C(C)C)CC1)(N[C@@H](Cc1ccccc1)C(=O)O)=O,Nateglinide has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 105816-04-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Repaglinide,c1c(c(ccc1)[C@H](CC(C)C)NC(=O)Cc1cc(c(cc1)C(O)=O)OCC)N1CCCCC1,Repaglinide has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 135062-02-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Pioglitazone,CCc1ccc(nc1)CCOc2ccc(cc2)CC3C(=O)NC(=O)S3.Cl,Pioglitazone has been linked to rare instances of acute liver injury.,0,CAS 111025-46-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Rosiglitazone,CN(CCOc1ccc(cc1)CC2C(=O)NC(=O)S2)c3ccccn3,Rosiglitazone has been linked to rare instances of acute liver injury.,0,CAS 122320-73-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Flucytosine,n1c(c(F)c[nH]c1=O)N,Flucytosine therapy can cause transient mild-to-moderate serum aminotransferase elevations and has been mentioned as a very rare cause of clinically apparent acute drug induced liver injury.,0,CAS 2022-85-7,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Griseofulvin,C1([C@@]2(Oc3c(c(OC)cc(OC)c13)Cl)C(=CC(=O)C[C@H]2C)OC)=O,Griseofulvin therapy can cause transient mild to moderate serum aminotransferase elevations and has very rarely been linked to clinically apparent acute drug induced liver injury.,0,CAS 126-07-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Pentamidine,c1(ccc(OCCCCCOc2ccc(C(N)=N)cc2)cc1)C(N)=N,Pentamidine has been associated with transient serum aminotransferase elevations during therapy and with rare instances of clinically apparent liver injury.,0,CAS 100-33-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ivermectin,C1[C@]2(O[C@H]3C[C@@H]1OC([C@H]1[C@@]4([C@H](OCC4=CC=C[C@@H]([C@@H](C(=CC3)C)O[C@H]3C[C@@H]([C@@H](O[C@@H]4C[C@@H]([C@@H](O)[C@@H](O4)C)OC)[C@@H](O3)C)OC)C)[C@@H](C(=C1)C)O)O)=O)O[C@@H]([C@H](CC2)C)[C@@H](CC)C.C1[C@]2(O[C@@H]3CC=C([C@@H](O[C@H]4C[C@@H]([C@@H](O[C@@H]5C[C@@H]([C@@H](O)[C@@H](O5)C)OC)[C@@H](O4)C)OC)[C@H](C=CC=C4[C@@]5([C@H](C(O[C@@H]1C3)=O)C=C(C)[C@H]([C@H]5OC4)O)O)C)C)O[C@@H]([C@@H](C)CC2)C(C)C,"Ivermectin therapy has been associated with minor, self-limiting serum aminotransferase elevations and very rare instances of clinically apparent liver injury.",0,CAS 70288-86-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Mebendazole,c12c([nH]c(n2)NC(OC)=O)ccc(c1)C(c1ccccc1)=O,"Mebendazole when given for prolonged periods in high doses has been associated with elevations in serum enzyme levels, and rare instances of acute, clinically apparent liver injury have been linked to its use.",0,CAS 31431-39-7,0,0,0,0,0,0,0,1,0,0,0,0,train,1
Cyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,Cyclizine has been linked to very rare instances of clinically apparent acute liver injury.,0,CAS 82-92-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Cyproheptadine,c43\C(=C1/CCN(C)CC1)c2ccccc2\C=C/c3cccc4,Cyproheptadine has been linked to rare instances of clinically apparent liver injury.,0,CAS 129-03-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,"Cetirizine and levocetirizine have been linked to rare, isolated instances of clinically apparent acute liver injury.",0,CAS 83881-51-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Fexofenadine,O=C(O)C(c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4)(C)C,Fexofenadine has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 83799-24-0,0,0,1,0,0,0,0,0,0,0,0,0,train,1
Loratadine,O=C(OCC)N4CC/C(=C2/c1ccc(Cl)cc1CCc3cccnc23)CC4,"Loratadine and desloratadine have been linked to rare, isolated instances of clinically apparent acute liver injury.",0,CAS 79794-75-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Desloratadine,Clc4cc2c(C(/c1ncccc1CC2)=C3/CCNCC3)cc4,"Loratadine and desloratadine have been linked to rare, isolated instances of clinically apparent acute liver injury.",0,CAS 100643-71-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Clofibrate,c1(OC(C(=O)OCC)(C)C)ccc(cc1)Cl,Clofibrate therapy is associated with mild and transient serum aminotransferase elevations and with rare instances of acute liver injury.,0,CAS 637-07-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Gemfibrozil,c1(c(ccc(c1)C)C)OCCCC(C(O)=O)(C)C,Gemfibrozil therapy is associated with mild and transient serum aminotransferase elevations and with rare instances of acute liver injury.,0,CAS 25812-30-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Atorvastatin,c1(c(n(CC[C@H](C[C@H](CC(=O)O)O)O)c(c1C(Nc1ccccc1)=O)C(C)C)c1ccc(F)cc1)c1ccccc1,"Atorvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy and rarely with clinically apparent acute liver injury.",0,CAS 134523-00-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ezetimibe,c1(ccc([C@H](CC[C@H]2C(=O)N(c3ccc(cc3)F)[C@@H]2c2ccc(cc2)O)O)cc1)F,"Ezetimibe therapy is associated with a low rate of serum aminotransferase elevations and clinically apparent liver injury due to ezetimibe occurs, but is rare.",0,CAS 163222-33-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Fluvastatin,[Na+].c1(c2c3ccccc3n(c2\C=C\[C@@H](C[C@@H](CC(=O)[O-])O)O)C(C)C)ccc(F)cc1,"Fluvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy and rarely with clinically apparent acute liver injury.",0,CAS 93957-54-1,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Lovastatin,C1[C@H](OC(=O)C[C@@H]1O)CC[C@@H]1[C@H]2[C@@H](OC([C@H](CC)C)=O)C[C@@H](C)C=C2C=C[C@@H]1C,"Lovastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy and rarely with clinically apparent acute liver injury.",0,CAS 75330-75-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Pitavastatin,c12ccccc1c(c(c(n2)C1CC1)\C=C\[C@H](C[C@H](CC(=O)O)O)O)c1ccc(cc1)F,"Pitavastatin is a relatively newly developed cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, but has had limited use and has yet to be linked with clinically apparent acute liver injury.",0,CAS 147526-32-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Pravastatin,C1=2C=C[C@H](C)[C@@H]([C@H]1[C@H](C[C@@H](O)C2)OC([C@H](CC)C)=O)CC[C@H](C[C@H](CC(O)=O)O)O,"Pravastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury.",0,CAS 81093-37-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Rosuvastatin,c1(nc(N(S(=O)(=O)C)C)nc(c1\C=C\[C@@H](C[C@H](CC(O)=O)O)O)c1ccc(cc1)F)C(C)C,"Rosuvastatin is a relatively newly developed cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury.",0,CAS 287714-41-4,0,0,0,1,0,0,0,0,0,0,0,0,train,1
Simvastatin,C1[C@H](OC(=O)C[C@@H]1O)CC[C@@H]1[C@H]2[C@@H](OC(C(CC)(C)C)=O)C[C@@H](C)C=C2C=C[C@@H]1C,"Simvastatin is a commonly used cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, and rarely with clinically apparent acute liver injury.",0,CAS 79902-63-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Artemisinin,O=C3O[C@@H]4O[C@@]1(OO[C@@]42[C@@H](CC1)[C@H](C)CC[C@H]2[C@H]3C)C,"Several artemisinin derivatives have been developed for clinical use in prevention and treatment of malaria, several of which have been linked to rare instances of acute liver injury.",0,CAS 63968-64-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Atovaquone,c1ccc2C(C(O)=[C@@](C3CC[C@@H](CC3)c3ccc(cc3)Cl)C(c2c1)=O)=O,Atovaquone therapy is associated with low rates of serum enzyme elevations and has been linked to only rare cases of clinically apparent liver injury.,0,CAS 95233-18-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Chloroquine,CCN(CC)CCCC(C)Nc1ccnc2c1ccc(c2)Cl,Chloroquine is not associated with serum enzyme elevations and is an extremely rare cause of clinically apparent acute liver injury.,0,CAS 54-05-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Proguanil,Clc1ccc(NC(=N/C(=N/C(C)C)N)N)cc1,"Proguanil has not been evaluated extensively as a single agent, but the combinations of proguanil with atovaquone or chloroquine have been used to treat malaria and have been linked to serum enzyme elevations during therapy and rare instances of clinically apparent acute liver injury.",0,CAS 500-92-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Quinine,[C@@H]12[C@H](CN([C@@H](C1)[C@@H](c1ccnc3c1cc(OC)cc3)O)CC2)C=C,Quinine therapy has been associated with rare instances of hypersensitivity reactions which can be accompanied by hepatitis and mild jaundice.,0,CAS 130-95-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Pyrimethamine,CCc1c(c(nc(n1)N)N)c2ccc(cc2)Cl,Pyrimethamine/ sulfadoxine has been linked with rare cases of idiosyncratic liver injury which resembles the hepatotoxicity associated with sulfonamides.,0,CAS 58-14-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Sulfadoxine,COc1c(ncnc1OC)NS(=O)(=O)c2ccc(cc2)N,Pyrimethamine/ sulfadoxine has been linked with rare cases of idiosyncratic liver injury which resembles the hepatotoxicity associated with sulfonamides.,0,CAS 2447-57-6,0,0,0,1,1,0,0,0,0,0,0,0,train,1
Epirubicin,O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)C[C@@](O)(C(=O)CO)C[C@@H]5O[C@@H]4O[C@H]([C@H](O)[C@@H](N)C4)C,"Epirubicin and idarubicin have similar profiles of activity and adverse events as doxorubicin, but have been less commonly used and their potential for causing liver injury has been less well defined.",0,CAS 56420-45-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Idarubicin,O=C2c1c(O)c5c(c(O)c1C(=O)c3ccccc23)C[C@@](O)(C(=O)C)C[C@@H]5O[C@@H]4O[C@H]([C@@H](O)[C@@H](N)C4)C,"Epirubicin and idarubicin have similar profiles of activity and adverse events as doxorubicin, but have been less commonly used and their potential for causing liver injury has been less well defined.",0,CAS 58957-92-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,"Mitoxantrone therapy is often accompanied by mild to moderate elevations in serum aminotransferase levels, but in typical doses it rarely causes clinically apparent, acute liver injury.",0,CAS 65271-80-9,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Fluorouracil,c1(c(c[nH]c([nH]1)=O)F)=O,Fluorouracil is associated with a low rate of transient serum aminotransferase elevations during therapy and has been implicated in rare cases of clinically apparent acute liver injury.,0,CAS 51-21-8,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Exemestane,O=C\1\C=C/[C@]3(C(=C/1)/C(=C)C[C@H]4[C@@H]2CCC(=O)[C@]2(CC[C@H]34)C)C,Exemestane has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.,0,CAS 107868-30-4,1,0,0,0,0,0,0,0,0,0,0,0,train,1
Letrozole,N#Cc1ccc(cc1)C(c2ccc(C#N)cc2)n3ncnc3,Letrozole has been associated with a low rate of serum enzyme elevations during therapy and rare instances of clinically apparent liver injury.,0,CAS 112809-51-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Erlotinib,n1cnc(c2cc(c(cc12)OCCOC)OCCOC)Nc1cc(ccc1)C#C,Erlotinib therapy is associated with transient elevations in serum aminotransferase levels during therapy and rare instances of clinically apparent acute liver injury.,0,CAS 183321-74-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Gefitinib,c12c(ncnc1cc(c(c2)OCCCN1CCOCC1)OC)Nc1cc(Cl)c(cc1)F,Gefitinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.,0,CAS 184475-35-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Lapatinib,c1cc2ncnc(Nc3ccc(c(c3)Cl)OCc3cccc(c3)F)c2cc1c1oc(cc1)CNCCS(=O)(=O)C,Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.,0,CAS 388082-78-8,0,0,0,0,0,0,0,0,0,0,1,0,train,1
Nilotinib,c1c(cc(cc1n1cc(nc1)C)NC(=O)c1cc(c(cc1)C)Nc1nccc(n1)c1cccnc1)C(F)(F)F,Nilotinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.,0,CAS 641571-10-0,0,0,0,0,0,0,0,0,1,0,0,0,test,1
Sunitinib,c1cc(cc2c1NC(=O)C\2=C/c1[nH]c(c(c1C)C(=O)NCCN(CC)CC)C)F,Sunitinib therapy is associated with transient elevations in serum aminotransferase and bilirubin levels and rare instances of clinically apparent acute liver injury.,0,CAS 557795-19-4,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Trihexyphenidyl,c1([C@@](C2CCCCC2)(CCN2CCCCC2)O)ccccc1,"Trihexyphenidyl has not been associated with serum enzyme elevations during treatment, but has been implicated in rare cases of acute liver injury.",0,CAS 144-11-6,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Levodopa,c1(c(ccc(c1)C[C@@H](C(O)=O)N)O)O,Treatment with the combination of levodopa and carbidopa has been associated with mild and transient increases in serum enzymes in a proportion of treated patients and with very rare instances of clinically apparent acute liver injury.,0,CAS 59-92-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Carbidopa,C([C@@](C(O)=O)(NN)C)c1cc(c(O)cc1)O.O,Treatment with the combination of levodopa and carbidopa has been associated with mild and transient increases in serum enzymes in a proportion of treated patients and with very rare instances of clinically apparent acute liver injury.,0,CAS 28860-95-9,0,1,0,0,0,0,0,0,0,0,0,0,train,1
Apomorphine,c12c3c4c(ccc(c4O)O)C[C@H]1[N@@](CCc2ccc3)C,"The use of apomorphine has been limited, but it has not been associated with serum enzyme elevations during treatment nor has it been implicated in cases of acute liver injury.",0,CAS 41372-20-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Bromocriptine,N12[C@@]([C@H]3N(CCC3)C([C@@H]2CC(C)C)=O)(O[C@@](C1=O)(NC([C@@H]1C=C2c3c4c(c(Br)[nH]c4ccc3)C[C@H]2[N@@](C1)C)=O)C(C)C)O,Bromocriptine therapy is associated with low rate of transient serum enzyme elevations during treatment and has been implicated in rare cases of acute liver injury.,0,CAS 25614-03-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Pergolide,CCCN1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4c3c2ccc4)CSC.CS(=O)(=O)O,Pergolide therapy is associated with low rate of transient serum enzyme elevations during treatment and has been implicated in rare cases of acute liver injury.,0,CAS 66104-22-1,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Fluphenazine,c1ccc2c(c1)N(c3cc(ccc3S2)C(F)(F)F)CCCN4CCN(CC4)CCO,Fluphenazine can cause mild and transient serum enzyme elevations and has been linked to rare instances of clinically apparent cholestatic liver injury.,0,CAS 69-23-8,0,0,0,0,0,0,0,0,1,0,0,1,train,1
Thioridazine,CN1CCCCC1CCN2c3ccccc3Sc4c2cc(cc4)SC,Thioridazine has been linked to rare instances of clinically apparent acute cholestatic liver injury.,0,CAS 50-52-2,0,0,0,0,0,0,1,0,0,0,0,1,train,1
Clozapine,CN1CCN(CC1)C2=Nc3cc(ccc3Nc4c2cccc4)Cl,Clozapine therapy is associated with serum aminotransferase elevations and in rare instances has been linked to clinically apparent acute liver injury.,0,CAS 5786-21-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Olanzapine,C=1(c2c(Nc3c(N1)cccc3)sc(c2)C)N1CCN(C)CC1,Olanzapine is not infrequently associated with serum aminotransferase elevations during therapy and there have been rare instances of clinically apparent acute liver injury linked to its use.,0,CAS 132539-06-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Quetiapine,c1ccc2c(c1)C(=Nc3ccccc3S2)N4CCN(CC4)CCOCCO,Use of quetiapine has been associated with serum aminotransferase elevations and in rare instances with clinically apparent acute liver injury.,0,CAS 111974-69-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Risperidone,Cc1c(c(=O)n2c(n1)CCCC2)CCN3CCC(CC3)c4c5ccc(cc5on4)F,Risperidone therapy is associated with serum aminotransferase elevations and in rare instances has been linked to clinically apparent acute liver injury.,0,CAS 106266-06-2,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Haloperidol,c1(C2(CCN(CCCC(c3ccc(F)cc3)=O)CC2)O)ccc(Cl)cc1,Haloperidol therapy is commonly associated with minor serum aminotransferase elevations and in very rare instances has been linked to clinically apparent acute liver injury.,0,CAS 52-86-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Loxapine,C1(=Nc2c(Oc3c1cc(cc3)Cl)cccc2)N1CCN(CC1)C,Loxapine therapy is commonly associated with minor serum aminotransferase elevations and in very rare instances has been linked to clinically apparent acute liver injury.,0,CAS 1977-10-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Molindone,C1OCCN(C1)C[C@@H]1CCc2c(C1=O)c(c([nH]2)C)CC,Molindone therapy is commonly associated with minor serum aminotransferase elevations but has rarely been linked to cases of clinically apparent acute liver injury.,0,CAS 7416-34-4,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Cyclosporine,C1(N[C@H](C(N(CC(N([C@H](C(N[C@@H](C(C)C)C(=O)N([C@H](C(N[C@@H](C)C(=O)N[C@@H](C(N([C@@H](C(N([C@H](C(N([C@@H](CC(C)C)C(N([C@H]1[C@@H]([C@@H](\C=C\C)C)O)C)=O)C)=O)CC(C)C)C)=O)CC(C)C)C)=O)C)=O)CC(C)C)C)=O)CC(C)C)C)=O)C)=O)CC)=O,Cyclosporine therapy can be associated with mild elevations in serum bilirubin and transient serum enzyme elevations and to rare instances of clinically apparent cholestatic liver injury.,0,CAS 59865-13-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Mycophenolate,C1OCCN(C1)CCOC(CCC(\C)=C/Cc1c(c(c2c(c1O)C(OC2)=O)C)OC)=O,Mycophenolate therapy can be associated with mild serum enzyme elevations and it has been linked to rare instances of clinically apparent liver injury.,0,CAS 128794-94-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Sirolimus,O1C([C@H]2N(CCCC2)C(C([C@@]2([C@H](C)CC[C@H](C[C@@H](C(=CC=CC=C[C@H](C[C@H](C([C@@H]([C@@H](C(C)=C[C@H](C(C[C@H]1[C@H](C)C[C@@H]1C[C@H]([C@@H](CC1)O)OC)=O)C)O)OC)=O)C)C)C)OC)O2)O)=O)=O)=O,Sirolimus therapy can be associated with mild serum enzyme elevations and it has been linked to rare instances of clinically apparent cholestatic liver injury.,0,CAS 53123-88-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC.O,Tacrolimus therapy can be associated with mild serum enzyme elevations and it has been linked to rare instances of clinically apparent cholestatic liver injury.,0,CAS 104987-11-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Baicalin,O=C3\C=C(/Oc2cc(O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O)c(O)c(O)c23)c4ccccc4,Flavocoxid has been linked to minor elevations in serum enzyme levels during therapy and to rare instances of clinically apparent liver injury.,0,CAS 330942-05-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,Flavocoxid has been linked to minor elevations in serum enzyme levels during therapy and to rare instances of clinically apparent liver injury.,0,CAS 51022-71-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Hydroxychloroquine,Clc1cc2nccc(c2cc1)NC(C)CCCN(CC)CCO,Hydroxychloroquine therapy has not been associated with liver function abnormalities and is an extremely rare cause of clinically apparent acute liver injury.,0,CAS 118-42-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Cycloserine,C1([C@@H](CON1)N)=O,"Cycloserine is appears to have little or no hepatotoxic potential, but it is usually used in combination with agents that are known to be hepatotoxic, and its role in the reported cases of liver injury with combination therapy cannot always be excluded.",0,CAS 68-41-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Rifabutin,N1C2(N=C3c4c5C(=O)C(NC(C(=CC=C[C@H](C)[C@@H]([C@@H](C)[C@H]([C@@H](C)[C@H](OC(=O)C)[C@@H]([C@H](C=CO[C@@]6(C)Oc(c4C6=O)c(C)c5O)OC)C)O)O)C)=O)=C13)CCN(CC2)CC(C)C,"Rifabutin is associated with transient and asymptomatic elevations in serum aminotransferase and is a likely cause of clinically apparent, acute liver disease.",0,CAS 72559-06-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Rifapentine,c12c3c4O[C@@](C3=O)(OC=C[C@@H]([C@@H]([C@H]([C@@H]([C@@H]([C@H](C)[C@@H]([C@@H](C=CC=C(C(Nc(c(c1c(O)c4C)O)c(c2O)\C=N\N1CCN(C2CCCC2)CC1)=O)C)C)O)O)C)OC(C)=O)C)OC)C,Rifapentine is associated with transient and asymptomatic elevations in serum aminotransferase and is a likely cause of clinically apparent acute liver injury.,0,CAS 61379-65-5,0,1,0,0,0,0,0,0,0,0,0,0,train,1
Famotidine,c1(nc(CSCC\C(=N/S(N)(=O)=O)N)cs1)\N=C(/N)N,Famotidine has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 76824-35-6,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Nizatidine,c1(nc(CSCCN\C(=C\[N+](=O)[O-])NC)cs1)CN(C)C,Nizatidine has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 76963-41-2,0,0,0,0,0,0,1,0,0,0,0,0,test,1
Ranitidine,c1(oc(CSCCN\C(=C\[N+](=O)[O-])NC)cc1)CN(C)C,Ranitidine has been linked to rare instances of clinically apparent acute liver injury.,0,CAS 66357-35-5,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Tenofovir,C[C@@H](Cn1cnc2c1ncnc2N)OCP(=O)(O)O,Tenofovir does not appear to be a significant cause of drug-induced liver injury.,0,CAS 147127-20-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Etravirine,C(#N)c1cc(c(c(c1)C)Oc1nc(nc(c1Br)N)Nc1ccc(cc1)C#N)C,Etravirine has been associated with transient serum aminotransferase elevations and with hypersensitivity reactions that can be associated with liver injury including acute liver failure.,0,CAS 269055-15-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Rilpivirine,C(#N)c1ccc(cc1)Nc1nccc(n1)Nc1c(cc(cc1C)/C=C/C#N)C,Rilpivirine is associated with a low rate of transient serum aminotransferase elevations during therapy and has been implicated in rare cases of clinically apparent acute liver injury.,0,CAS 500287-72-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Atazanavir,C([C@@H](NC(=O)OC)C(C)(C)C)(N[N@@](C[C@@H]([C@@H](NC([C@@H](NC(=O)OC)C(C)(C)C)=O)Cc1ccccc1)O)Cc1ccc(c2ncccc2)cc1)=O,"Atazanavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels, mild elevations in indirect bilirubin concentration, and rarely clinically apparent, acute liver injury.",0,CAS 198904-31-3,0,1,0,0,0,0,0,0,0,0,0,0,train,1
Darunavir,CC(C)CN(C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)c4ccc(cc4)N,"Darunavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent, acute liver injury.",0,CAS 206361-99-1,0,0,0,1,1,0,0,0,0,0,0,0,train,1
Maraviroc,C1[C@H]2N([C@@H](C[C@H]1n1c(nnc1C(C)C)C)CC2)CC[C@@H](c1ccccc1)NC(C1CCC(CC1)(F)F)=O,"Maraviroc has been associated with elevations in serum aminotransferase levels and to several cases of acute, clinically apparent liver injury.",0,CAS 376348-65-1,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Valacyclovir,O=C(OCCOCn1c2N\C(=N/C(=O)c2nc1)N)[C@@H](N)C(C)C,"Valacyclovir has been associated with rare instances mild, clinically apparent liver injury.",0,CAS 124832-26-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Atomoxetine,CC1=C(C=CC=C1)O[C@H](CCNC)C2=CC=CC=C2,"Atomoxetine has been linked to a low rate of serum aminotransferase elevations and to rare cases of acute, clinically apparent liver injury.",0,CAS 82248-59-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Azithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,Azithromycin has been linked to rare instances of acute liver injury.,0,CAS 83905-01-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Chlordiazepoxide,c12C(c3ccccc3)=[N+](CC(=Nc1ccc(c2)Cl)NC)[O-],"As with other benzodiazepines, chlordiazepoxide therapy is not associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from chlordiazepoxide has been reported but is very rare.",0,CAS 58-25-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Flurazepam,CCN(CC)CCN1c2ccc(cc2C(=NCC1=O)c3ccccc3F)Cl.Cl.Cl,"As with most benzodiazepines, flurazepam therapy has not associated with serum aminotransferase or alkaline phosphatase elevations; clinically apparent liver injury from flurazepam has been reported but is very rare.",0,CAS 17617-23-1,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Triazolam,c12c(C(c3c(cccc3)Cl)=NCc3n1c(nn3)C)cc(Cl)cc2,"As with most benzodiazepines, triazolam therapy has not been associated with serum aminotransferase or alkaline phosphatase elevations, and clinically apparent liver injury from triazolam has been reported but is very rare.",0,CAS 28911-01-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Bosentan,CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2c(c(nc(n2)c3ncccn3)OCCO)Oc4ccccc4OC,Bosentan has been associated with serum enzyme elevations during therapy and with rare instances of clinically apparent acute liver injury.,0,CAS 147536-97-8,0,0,0,1,0,0,0,0,0,0,0,0,train,1
Ertapenem,C1(=C(S[C@@H]2CN[C@@H](C2)C(=O)Nc2cccc(c2)C(O)=O)[C@@H]([C@H]2N1C(=O)[C@@H]2[C@H](O)C)C)C(O)=O,"Ertapenem like other carbapenems is associated with transient and asymptomatic elevations in serum enzymes. The carbapenems have also been linked to rare instances of clinically apparent, acute cholestatic liver injury.",0,CAS 153832-46-3,0,0,0,0,0,0,1,0,0,0,0,0,train,1
Piperacillin,N12[C@H]([C@H](NC([C@@H](c3ccccc3)NC(N3C(C(N(CC)CC3)=O)=O)=O)=O)C2=O)SC(C)(C)[C@H]1C(=O)[O-].[Na+],"Piperacillin has been linked with idiosyncratic liver injury, but only rarely and in isolated case reports.",0,CAS 66258-76-2,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ticarcillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](c3ccsc3)C(=O)O)C(=O)O)C,Ticarcillin has been linked with idiosyncratic liver injury but only rarely and as isolated case reports.,0,CAS 34787-01-4,0,0,1,0,0,0,0,0,0,0,0,0,train,1
Tazobactam,S1([C@](C)([C@@H](N2C(C[C@@H]12)=O)C(=O)O)Cn1nncc1)(=O)=O,Piperacillin/tazobactam has been linked with idiosyncratic liver injury but only rarely and as isolated case reports.,0,CAS 89786-04-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Celecoxib,n1(c(c2ccc(C)cc2)cc(n1)C(F)(F)F)c1ccc(S(N)(=O)=O)cc1,Celecoxib has been linked to rare instances of idiosyncratic drug-induced liver disease.,0,CAS 169590-42-5,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Clarithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Clarithromycin has been linked to rare instances of acute liver injury.,0,CAS 81103-11-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Clindamycin,CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,Clindamycin has been linked to rare instances of acute liver injury.,0,CAS 18323-44-9,0,0,0,0,0,0,1,0,1,0,0,0,train,1
Dicloxacillin,Cc1c(c(no1)c2c(cccc2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,"Dicloxacillin has been linked to rare instances of clinically apparent, idiosyncratic liver injury",0,CAS 3116-76-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Nafcillin,O=C(O)[C@@H]3N4C(=O)[C@@H](NC(=O)c2c1ccccc1ccc2OCC)[C@H]4SC3(C)C,"Nafcillin has been linked to rare occurrences of clinically apparent, idiosyncratic liver injury.",0,CAS 985-16-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Oxacillin,Cc1c(c(no1)c2ccccc2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,"Oxacillin has been linked to rare instances of clinically apparent, idiosyncratic liver injury, but it more commonly causes transient elevations in serum aminotransferases without jaundice.",0,CAS 66-79-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Methylphenidate,c1([C@@H]([C@@H]2CCCCN2)C(OC)=O)ccccc1,"Methylphenidate has been linked to a low rate of serum aminotransferase elevations during therapy and to rare instances of acute, clinically apparent liver injury, generally after its intravenous abuse.",0,CAS 113-45-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Dapsone,S(c1ccc(N)cc1)(c1ccc(N)cc1)(=O)=O,Dapsone has been linked with rare cases of idiosyncratic liver injury similar to that seen with the sulfonamides.,0,CAS 80-08-0,0,0,0,0,1,0,0,0,0,0,0,0,train,1
Demeclocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](c4c(ccc(c4C(=O)C3=C([C@@]2(C(=O)C(=C1O)C(=O)N)O)O)O)Cl)O.Cl,"While demeclocycline has not been linked specifically to liver injury in the published literature, it is an orally available semisynthetic tetracycline and is likely to cause injury similar to that described for tetracycline, oxytetracycline, and doxycycline. Because it is not commonly used, its potential for causing liver injury may not have been fully defined.",0,CAS 127-33-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Diflunisal,c1(c2cc(c(O)cc2)C(O)=O)c(cc(F)cc1)F,"Diflunisal has been linked mild, transient elevations in serum aminotransferase levels during therapy as well as to rare instances of idiosyncratic drug-induced liver disease.",0,CAS 22494-42-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Spironolactone,O=C5O[C@@]4([C@@]3([C@H]([C@@H]2[C@H](SC(=O)C)C/C1=C/C(=O)CC[C@]1(C)[C@H]2CC3)CC4)C)CC5,Spironolactone has been linked to rare cases of clinically apparent drug-induced liver disease.,0,CAS 52-01-7,1,0,0,0,0,0,1,0,0,0,0,0,train,1
Triamterene,c1ccc(cc1)c2c(nc3c(n2)c(nc(n3)N)N)N,Triamterene has been linked to rare cases of clinically apparent drug-induced liver disease.,0,CAS 396-01-0,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Doxycycline,C[C@H]1c2cccc(c2C(=O)C3=C([C@]4([C@@H]([C@H]([C@H]13)O)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O,Doxycycline is a semisynthetic tetracycline-related bacteriostatic antibiotic that has been linked to rare instances of acute cholestatic liver injury.,0,CAS 564-25-0,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Sildenafil,c1(c2nc3c(c(=O)[nH]2)n(nc3CCC)C)c(ccc(c1)S(=O)(=O)N1CCN(CC1)C)OCC,Sildenafil has been associated with rare instances of clinically apparent liver injury.,0,CAS 139755-83-2,0,0,0,1,0,0,0,0,0,0,0,0,test,1
Tadalafil,C1N(C([C@H]2Cc3c([C@H](N2C1=O)c1ccc2c(c1)OCO2)[nH]c1ccccc31)=O)C,Tadalafil therapy has not been associated with serum aminotransferase elevations but has been linked to at least one published case of clinically apparent liver injury.,0,CAS 171596-29-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Etodolac,c12[C@@](OCCc1c1cccc(c1[nH]2)CC)(CC(O)=O)CC,Etodolac has been linked to rare instances of clinically apparent drug-induced liver disease.,0,CAS 41340-25-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Levofloxacin,C[C@H]1COc2c3n1cc(c(=O)c3cc(c2N4CCN(CC4)C)F)C(=O)O,"Levofloxacin has been linked to rare instances of clinically apparent hepatic injury marked by a short latency period and a hepatocellular pattern of enzyme elevations, similar to what has been described with ciprofloxacin.",0,CAS 100986-85-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Norfloxacin,c12c(c(=O)c(cn1CC)C(=O)O)cc(c(c2)N1CCNCC1)F,Norfloxacin has been linked to rare instances of acute hepatocellular injury.,0,CAS 70458-96-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Ofloxacin,CC1COc2c3n1cc(c(=O)c3cc(c2N4CCN(CC4)C)F)C(=O)O,Ofloxacin has been linked to rare instances of acute hepatocellular injury.,0,CAS 82419-36-1,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Ibuprofen,c1([C@@H](C(O)=O)C)ccc(CC(C)C)cc1,"Ibuprofen is considered to be among the safest NSAIDs and is generally well tolerated but can, nevertheless, rarely cause clinically apparent and serious acute liver injury.",0,CAS 15687-27-1,0,0,1,0,0,0,0,0,0,0,0,0,train,1
Indomethacin,Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)O,Indomethacin has been associated with rare cases of idiosyncratic drug-induced liver disease.,0,CAS 53-86-1,0,0,1,0,0,0,0,1,0,0,0,0,test,1
Topotecan,O=C\1N4\C(=C/C2=C/1COC(=O)[C@]2(O)CC)c3nc5c(cc3C4)c(c(O)cc5)CN(C)C,Both irinotecan and topotecan are associated with an appreciable rate of serum enzyme elevations during therapy and irinotecan has been implicated in causing steatohepatitis when given as cyclic anticancer therapy.,0,CAS 119413-54-6,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Ketoprofen,c1cc(ccc1)C(c1cccc(c1)[C@@H](C(O)=O)C)=O,Ketoprofen has been linked to a low rate of serum enzyme elevations during therapy and to rare instances of clinically apparent acute liver injury.,0,CAS 22071-15-4,0,0,1,0,0,0,0,1,0,0,0,0,train,1
Linezolid,CC(=O)NC[C@@H]1CN(C(=O)O1)c2ccc(c(c2)F)N3CCOCC3,Prolonged therapy with linezolid has been linked to rare instances of lactic acidosis and liver injury probably as a result of hepatic mitochondrial toxicity.,0,CAS 165800-03-3,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Lorcaserin,Clc1cc2c(cc1)CCNC[C@@H]2C,"Lorcaserin has been in clinical use for a short time only, but has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent liver injury.",0,CAS 616202-92-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Mefenamic acid,c1(c(cccc1)C(=O)O)Nc1c(c(ccc1)C)C,"Mefanamic acid has been linked to rare instances of clinically apparent, acute liver injury.",0,CAS 61-68-7,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Meloxicam,N(C(C=1N(S(c2ccccc2C1O)(=O)=O)C)=O)c1sc(cn1)C,"Meloxicam has been linked to rare instances of acute, clinically apparent liver injury.",0,CAS 71125-38-7,0,0,0,1,0,0,0,0,0,0,0,0,train,1
Metronidazole,Cc1ncc(n1CCO)[N+](=O)[O-],"Metronidazole has been linked to rare instances of acute, clinically apparent liver injury.",0,CAS 443-48-1,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Nabumetone,c12c(cc(OC)cc2)ccc(c1)CCC(C)=O,"Nabumetone has been linked to rare instances of clinically apparent, idiosyncratic drug-induced liver disease.",0,CAS 42924-53-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Naltrexone,c12[C@]34[C@@]5([C@H]([N@](CC6CC6)CC4)Cc2ccc(c1O[C@H]3C(=O)CC5)O)O,Naltrexone has been associated with low rates of serum enzyme elevations during therapy and with rare instances of clinically apparent liver injury.,0,CAS 16590-41-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Naproxen,c12c(cc(OC)cc2)ccc(c1)[C@@H](C(O)=O)C,Naproxen has been associated with rare cases of clinically apparent drug-induced liver injury.,0,CAS 22204-53-1,0,0,1,0,0,0,0,0,0,0,0,0,train,1
Rofecoxib,CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3,Rofecoxib had also been linked transient serum aminotransferase elevations during therapy and to rare instances of idiosyncratic drug-induced liver disease.,0,CAS 162011-90-7,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Tolmetin,c1(C(=O)c2ccc(cc2)C)n(c(cc1)CC(=O)O)C,Tolmetin is associated with low rates of serum aminotransferase elevations during therapy and has been linked to rare instances of clinically apparent drug-induced liver injury.,0,CAS 26171-23-3,0,0,1,0,0,0,0,1,0,0,0,0,train,1
Oxaprozin,c1(c(oc(n1)CCC(O)=O)c1ccccc1)c1ccccc1,Oxaprozin has been linked to rare instances of idiosyncratic drug-induced liver disease.,0,CAS 21256-18-8,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Riluzole,s1c(nc2c1cc(cc2)OC(F)(F)F)N,"Riluzole is associated with a low rate of serum aminotransferase elevations during therapy and has been linked to rare instances of clinically apparent, acute liver injury.",0,CAS 1744-22-5,0,0,0,0,0,0,0,0,1,0,0,0,train,1
Ropinirole,CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl,Ropinirole therapy is associated with low rate of transient serum enzyme elevations during treatment and has been implicated in rare cases of acute liver injury.,0,CAS 91374-21-9,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Salsalate,c1ccc(c(c1)C(=O)Oc2ccccc2C(=O)O)O,Salsalate can cause moderate serum aminotransferase elevations when given in high doses in a manner similar to aspirin.,0,CAS 552-94-3,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Varenicline,n1ccnc2c1cc1c([C@@H]3CNC[C@@H]1C3)c2,"Varenicline has been associated with a low rate of serum enzyme elevations during therapy, and since approval and its wide-scale use, with rare instances of clinically apparent mild liver injury.",0,CAS 249296-44-4,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Sulfamethoxazole,Cc1cc(no1)NS(=O)(=O)c2ccc(cc2)N,"Sulfamethoxazole with trimethoprim is a fixed antibiotic combination that is widely used for mild to moderate bacterial infections and as prophylaxis against opportunistic infections.  Like other sulfonamide-containing medications, this combination has been linked to rare instances of clinically apparent acute liver injury. ",0,CAS 723-46-6,0,0,0,1,1,0,0,0,0,0,0,0,train,1
Trimethoprim,COc1cc(cc(c1OC)OC)Cc2cnc(nc2N)N,"Sulfamethoxazole with trimethoprim is a fixed antibiotic combination that is widely used for mild to moderate bacterial infections and as prophylaxis against opportunistic infections.  Like other sulfonamide-containing medications, this combination has been linked to rare instances of clinically apparent acute liver injury. ",0,CAS 738-70-5,0,0,0,0,0,0,0,0,0,0,0,0,train,1
Tibolone,[C@H]12[C@H]3[C@@]([C@@](CC3)(C#C)O)(CC[C@@H]1C1=C(C[C@H]2C)CC(=O)CC1)C,"Tibolone has been associated with rare instances of acute, clinically apparent liver injury.",0,CAS 5630-53-5,0,0,0,0,0,0,0,0,0,0,0,0,test,1
Abacavir sulfate,c1nc2c(nc(nc2n1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4,Abacavir is a rare cause of clinically apparent drug induced liver injury,1,CAS 136470-78-5,0,0,0,0,0,0,0,0,0,1,0,0,train,2
Lisinopril,N1([C@@H](CCC1)C(O)=O)C([C@@H](N[C@@H](CCc1ccccc1)C(O)=O)CCCCN)=O.O.O,Lisinopril is associated with a low rate of transient serum aminotransferase elevations and has been linked to rare instances of acute liver injury that can be severe and even fatal.,1,CAS 83915-83-7,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Acetohexamide,S(=O)(=O)(c1ccc(cc1)C(=O)C)NC(=O)NC1CCCCC1,"well known, but rare causes of clinically apparent liver injury.",1,CAS 968-81-0,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Chlorpropamide,c1(S(=O)(=O)NC(=O)NCCC)ccc(cc1)Cl,"well known, but rare causes of clinically apparent liver injury.",1,CAS 94-20-2,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Tolazamide,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2,"well known, but rare causes of clinically apparent liver injury.",1,CAS 1156-19-0,0,1,0,1,0,0,0,0,0,0,0,0,train,2
Tolbutamide,CCCCNC(=O)NS(=O)(=O)c1ccc(cc1)C,"well known, but rare causes of clinically apparent liver injury.",1,CAS 64-77-7,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Acitretin,c1(c(c(c(OC)cc1C)C)C)\C=C\C(=C\C=C\C(=C\C(O)=O)C)C,"Acitretin, like many retinoids, can lead to increase in serum aminotransferase levels and has been implicated in cases of acute liver injury which can be severe and even fatal.",1,CAS 55079-83-9,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Busulfan,O(S(C)(=O)=O)CCCCOS(C)(=O)=O,"Busulfan has been linked to transient serum enzyme elevations during therapy, to rare cases of cholestatic hepatitis, instances of nodular regenerative hyperplasia and, when given in high doses, to sinusoidal obstruction syndrome which can be severe and fatal.",1,CAS 55-98-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Carmustine,ClCCNC(=O)N(CCCl)N=O,Carmustine therapy is associated with minor transient serum enzyme elevations and has been linked to cases of acute liver injury including cholestatic hepatitis and acute veno-occlusive disease.,1,CAS 154-93-8,0,1,0,0,0,0,0,0,1,0,0,0,test,2
Dacarbazine,c1(c(nc[nH]1)C(=O)N)/N=N/N(C)C,"Dacarbazine therapy has been associated with serum enzyme elevations during therapy and occasional cases of severe and distinctive acute hepatic failure, probably caused by acute sinusoidal obstruction syndrome.",1,CAS 4342-03-4,0,1,0,0,0,0,0,0,0,0,0,0,test,2
Ifosfamide,O=P1(OCCCN1CCCl)NCCCl,"Ifosfamide therapy is associated with minor transient serum enzyme elevations and has been linked to cases of acute liver injury, including acute cholestatic hepatitis and veno-occlusive disease.",1,CAS 3778-73-2,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Allopurinol,c12c([nH]cnc1=O)[nH]nc2,Allopurinol is a rare but well known cause of acute liver injury that has features of a hypersensitivity reaction and can be severe and even fatal.,1,CAS 315-30-0,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Labetalol,CC(CCc1ccccc1)NCC(c2ccc(c(c2)C(=O)N)O)O,Labetalol has been linked to several cases of clinically apparent drug-induced liver disease some of which have been severe and even fatal.,1,CAS 36894-69-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Methyldopa,C[C@](Cc1ccc(c(c1)O)O)(C(=O)O)N,Methyldopa has been clearly linked to instances of acute and chronic liver injury that can be severe and even fatal.,1,CAS 555-30-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Hydralazine,c\12c(cn[nH]c1=N/N)cccc2,Hydralazine has been linked to several forms of acute liver injury as well as a lupus-like syndrome.,1,CAS 86-54-4,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Rivastigmine,c1c(OC(=O)N(C)CC)cc([C@@H](N(C)C)C)cc1,Rivastigmine is associated with a minimal rate of serum enzyme elevations during therapy and is a rare cause of clinically apparent liver injury.,1,CAS 123441-03-2,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Clavulanic Acid,N12[C@H](/C(=C/CO)O[C@@H]1CC2=O)C(=O)O,"Amoxicillin/clavulanate is currently the most common cause of clinically apparent, drug induced acute liver injury both in the United States and Europe.",1,CAS 58001-44-8,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Amiodarone,c1(c2c(oc1CCCC)cccc2)C(=O)c1cc(c(c(c1)I)OCCN(CC)CC)I,Amiodarone is a potent arrhythmia suppressing agent that has been clearly linked to several distinct forms of drug induced liver disease.,1,CAS 1951-25-3,0,0,0,0,0,0,0,1,0,0,0,0,train,2
Amitriptyline,C1(\c2c(CCc3c1cccc3)cccc2)=C\CCN(C)C,Amitriptyline can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute cholestatic liver injury.,1,CAS 50-48-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Amodiaquine,CCN(CC)Cc1cc(ccc1O)Nc2ccnc3c2ccc(c3)Cl,"Amodiaquine has been linked to severe cases of acute hepatitis which can be fatal, for which reason it is recommended for use only as treatment and not for prophylaxis against malaria.",1,CAS 86-42-0,0,0,0,0,0,0,0,0,0,0,1,0,train,2
Amprenavir,c1c(ccc(c1)N)S([N@@](C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@@H]1COCC1)O)CC(C)C)(=O)=O,"Both amprenavir and fosamprenavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and are rare causes of clinically apparent, acute liver injury.",1,CAS 161814-49-9,0,0,0,1,1,0,0,0,0,0,0,0,train,2
Fosamprenavir,C1COC[C@H]1OC(=O)N[C@@H](Cc1ccccc1)[C@@H](C[N@@](S(=O)(=O)c1ccc(N)cc1)CC(C)C)OP(O)(=O)O,"Both amprenavir and fosamprenavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and are rare causes of clinically apparent, acute liver injury.",1,CAS 226700-79-4,0,0,0,1,1,0,0,0,0,0,0,0,train,2
Danazol,C1[C@H]2[C@H]([C@H]3[C@@]([C@@](C#C)(O)CC3)(C)C1)CCC=1[C@@]2(Cc2cnoc2C1)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 17230-88-5,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Fluoxymesterone,[C@@]12([C@H]([C@H]3[C@](C[C@@H]2O)([C@@](CC3)(C)O)C)CCC2=CC(=O)CC[C@]12C)F,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 76-43-7,1,0,0,0,0,0,0,0,1,0,0,0,test,2
Methandienone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CCC4=CC(=O)C=C[C@]34C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 72-63-9,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Methenolone,[C@@H]12[C@@H]([C@@]3(C(CC2)CC(=O)C=C3C)C)CC[C@]2([C@H]1CC[C@@H]2OC(=O)CCCCCC)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 303-42-4,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Methyltestosterone,C1[C@@H]2[C@@H]([C@@]3(C(=CC(=O)CC3)C1)C)CC[C@@]1([C@H]2CC[C@]1(C)O)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 58-18-4,1,0,0,0,0,0,0,0,0,0,0,0,test,2
Nandrolone,C1[C@H]2[C@H]3[C@H](CC[C@@]2([C@H](OC(CCCCCCCCC)=O)C1)C)[C@@H]1C(=CC(=O)CC1)CC3,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 434-22-0,1,0,0,0,0,0,0,0,0,0,0,0,test,2
Norethandrolone,C1[C@@H]2[C@@]([C@@](CC)(O)C1)(CC[C@H]1[C@H]2CCC=2[C@@H]1CCC(C2)=O)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 52-78-8,1,0,0,0,0,0,0,0,0,0,0,0,test,2
Oxandrolone,C1[C@@H]2[C@@H]([C@@]3([C@@H](CC(=O)OC3)C1)C)CC[C@@]1([C@H]2CC[C@]1(C)O)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 53-39-4,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Oxymetholone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C\O)/C(=O)C4)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 434-07-1,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Stanozolol,C1[C@H]2[C@H]([C@H]3[C@@]([C@@](C)(O)CC3)(C)C1)CC[C@@H]1[C@@]2(Cc2cn[nH]c2C1)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 10418-03-8,1,0,0,0,0,0,0,0,0,0,0,0,test,2
Testosterone,[C@@H]12[C@@H]([C@@]3(C(=CC(=O)CC3)CC2)C)CC[C@]2([C@H]1CC[C@@H]2OC(=O)CCC1CCCC1)C,Many synthetic androgenic steroids are capable of causing cholestatic liver injury and long term use of androgens is associated with development of liver tumors including hepatocellular carcinoma and hepatic adenoma.,1,CAS 58-22-0,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Enflurane,C([C@@H](F)Cl)(OC(F)F)(F)F,"Case series and isolated case reports of severe acute liver injury similar to halothane hepatitis attributed to enflurane have been published, but are rare.",1,CAS 13838-16-9,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Halothane,C([C@@H](Cl)Br)(F)(F)F,Halothane is a potent volatile halogenated anesthetic gas that has been linked to many cases of idiosyncratic acute liver injury that are frequently severe. ,1,CAS 151-67-7,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Isoflurane,C([C@@H](OC(F)F)Cl)(F)(F)F,Isoflurane has been linked to rare instances of severe acute liver injury resembling halothane induced liver injury in small case series and individual case reports.,1,CAS 26675-46-7,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"Long term ketamine use can cause inflammation and irritation to the urinary bladder and urethra, and similar changes have recently been described in the biliary tract, resulting in an acute or chronic cholestatic liver injury that can resemble sclerosing cholangitis.",1,CAS 6740-88-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Flutamide,c1(c(ccc(c1)NC(C(C)C)=O)[N+](=O)[O-])C(F)(F)F,"Flutamide is frequently associated with minor serum aminotransferase elevations and has been linked to numerous cases of acute liver injury, which are frequently severe and can be fatal.",1,CAS 13311-84-7,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Disopyramide,CC(C)N(CCC(c1ccccc1)(c2ccccn2)C(=O)N)C(C)C,Long term disopyramide therapy is associated with a low rate of serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.,1,CAS 3737-09-5,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Flecainide,c1(c(OCC(F)(F)F)ccc(c1)OCC(F)(F)F)C(NC[C@@H]1CCCCN1)=O,Long term flecainide therapy is associated with a low rate of serum enzyme elevations and is a very rare cause of clinically apparent acute liver injury.,1,CAS 54143-55-4,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Mexiletine,c1ccc(c(OC[C@@H](N)C)c1C)C,Long term mexiletine therapy is associated with a low rate of serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.,1,CAS 31828-71-4,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Procainamide,c1(C(=O)NCCN(CC)CC)ccc(cc1)N,"Long term procainamide therapy is known to induce hypersensitivity reactions, autoantibody formation and a lupus-like syndrome but is a rare cause of clinically apparent acute liver injury.",1,CAS 51-06-9,0,0,0,0,1,0,0,0,0,0,0,0,train,2
Quinidine,c12c([C@@H]([C@@H]3N4C[C@@H](C(C3)CC4)C=C)O)ccnc1ccc(c2)OC,"Quinidine has been associated with fever, mild jaundice and clinically apparent liver injury in up to 2% of treated patients.",1,CAS 56-54-2,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Zafirlukast,c12c(Cc3c(cc(C(NS(c4ccccc4C)(=O)=O)=O)cc3)OC)cn(c1ccc(c2)NC(OC1CCCC1)=O)C,Zafirlukast has been linked to rare but occasionally severe cases of acute liver injury.,1,CAS 107753-78-6,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Aspirin,c1(c(cccc1)OC(C)=O)C(O)=O,"Aspirin can cause several forms of liver injury:  in high doses, aspirin can cause moderate to marked serum aminotransferase elevations occasionally with jaundice or signs of liver dysfunction, and in lower doses in susceptible children with a febrile illness aspirin can lead to Reye syndrome.",1,CAS 50-78-2,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Carbamazepine,N1(c2c(cccc2)C=Cc2c1cccc2)C(N)=O,Carbamazepine is an aromatic anticonvulsant that is widely used in therapy of epilepsy and trigeminal neuralgia and is a well known cause of clinically apparent acute drug induced liver injury which can be severe and even fatal.,1,CAS 298-46-4,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Felbamate,C(c1ccccc1)(COC(=O)N)COC(=O)N,Felbamate has been associated with multiple cases of aplastic anemia and acute liver failure and its use is now restricted.,1,CAS 25451-15-4,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Fosphenytoin,c1ccc(cc1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)c3ccccc3,"While not specifically associated with cases of drug induced liver injury, fosphenytoin is converted to phenytoin which is a well known cause of acute idiosyncratic drug induced liver disease.",1,CAS 93390-81-9,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Lamotrigine,c1(c2c(c(ccc2)Cl)Cl)c(nc(N)nn1)N,"Lamotrigine is a widely used antiseizure medication that is a rare but well known cause of idiosyncratic liver injury, that can be severe and even fatal.",1,CAS 84057-84-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,Phenobarbital is a barbiturate that is widely used as a sedative and an antiseizure medication.  Phenobarbital has been linked to rare instances of idiosyncratic liver injury that can be severe and even fatal.,1,CAS 50-06-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Phenytoin,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,"Phenytoin, formerly known as diphenylhydantoin, is perhaps the most commonly used major anticonvulsant agent, and is a rare but well known cause of acute idiosyncratic drug induced liver disease that can be severe and even fatal.",1,CAS 57-41-0,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Valproate,CCCC(CCC)C(O)=O,"Valproate or valproic acid is a branched chain organic acid that is used as therapy of epilepsy, bipolar disorders and migraine headaches and is a well known cause of several distinctive forms of acute and chronic liver injury.",1,CAS 76584-70-8,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Clomipramine,N1(CCCN(C)C)c2c(CCc3ccccc13)ccc(c2)Cl,Clomipramine can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute liver injury.,1,CAS 303-49-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Desipramine,N1(c2c(CCc3c1cccc3)cccc2)CCCNC,Desipramine can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute cholestatic liver injury.,1,CAS 50-47-5,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Doxepin,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,Doxepin can cause mild and transient serum enzyme elevations but is rare cause of clinically apparent acute cholestatic liver injury.,1,CAS 1668-19-5,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Imipramine,N1(c2c(CCc3c1cccc3)cccc2)CCCN(C)C,Imipramine can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute cholestatic liver injury.,1,CAS 50-49-7,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Nortriptyline,C1(\c2c(CCc3c1cccc3)cccc2)=C\CCNC,Nortriptyline can cause mild and transient serum enzyme elevations and is rare cause of clinically apparent acute and chronic cholestatic liver injury.,1,CAS 72-69-5,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Gliclazide,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,"These agents are known, but infrequent causes of clinically apparent liver injury.",1,CAS 21187-98-4,0,1,0,1,0,0,0,0,0,0,0,0,train,2
Glimepiride,C1C(C)=C(CC)C(=O)N1C(NCCc1ccc(S(NC(N[C@@H]2CC[C@H](CC2)C)=O)(=O)=O)cc1)=O,"These agents are known, but infrequent causes of clinically apparent liver injury.",1,CAS 93479-97-1,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Glipizide,Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,"These agents are known, but infrequent causes of clinically apparent liver injury.",1,CAS 29094-61-9,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Glyburide,c1(Cl)cc(c(OC)cc1)C(NCCc1ccc(cc1)S(NC(NC1CCCCC1)=O)(=O)=O)=O,"These agents are known, but infrequent causes of clinically apparent liver injury.",1,CAS 10238-21-8,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Troglitazone,c12c(CC[C@@](O1)(COc1ccc(C[C@@H]3C(NC(S3)=O)=O)cc1)C)c(c(O)c(c2C)C)C,withdrawn 3 years later because of the frequency of liver injury including acute liver failure associated with its use,1,CAS 97322-87-7,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Fluconazole,c1c(cc(c(C(Cn2ncnc2)(O)Cn2cncn2)c1)F)F,Fluconazole therapy can cause transient mild to moderate serum aminotransferase elevations and is a rare cause of clinically apparent acute drug induced liver injury.,1,CAS 86386-73-4,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Ketoconazole,c1(cc(c(cc1)[C@@]1(O[C@H](COc2ccc(cc2)N2CCN(CC2)C(C)=O)CO1)Cn1cncc1)Cl)Cl,Ketoconazole is a well documented cause of clinically apparent acute drug induced liver injury.,1,CAS 65277-42-1,0,0,0,0,0,0,0,0,0,0,1,0,train,2
Terbinafine,CC(C)(C)C#C/C=C/CN(C)Cc1cccc2c1cccc2,Terbinafine has been clearly linked to rare instances of acute liver injury that can be severe and sometimes fatal.,1,CAS 91161-71-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Voriconazole,c1(c([C@@]([C@H](c2ncncc2F)C)(Cn2cncn2)O)ccc(F)c1)F,"Voriconazole therapy is associated with transient, asymptomatic serum aminotransferase elevations and is a rare cause of clinically apparent acute drug induced liver injury.",1,CAS 137234-62-9,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Benzbromarone,c1(c2c(oc1CC)cccc2)C(=O)c1cc(c(c(c1)Br)O)Br,"Benzbromarone is a nonpurine xanthine oxidase inhibitor used for the treatment of gout, but never approved for use in the United States because of concerns over reports of acute liver injury and deaths with its use.",1,CAS 3562-84-3,0,0,0,0,0,0,0,1,0,0,0,0,train,2
Thiabendazole,c1ccc2c(c1)[nH]c(n2)c3cscn3,Thiabendazole therapy has been shown to cause clinically apparent cholestatic liver injury which is rare but can be severe.,1,CAS 148-79-8,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Fenofibrate,c1(C(c2ccc(Cl)cc2)=O)ccc(OC(C(OC(C)C)=O)(C)C)cc1,"Fenofibrate therapy is associated with mild and transient serum aminotransferase elevations and with rare instances of acute liver injury, which can be severe and prolonged and lead to significant hepatic fibrosis.",1,CAS 49562-28-9,0,0,0,0,0,0,0,1,0,0,0,0,train,2
Niacin,c1(cccnc1)C(O)=O,"Niacin can cause mild-to-moderate serum aminotransferase elevations and high doses and certain formulations of niacin have been linked to clinically apparent, acute liver injury which can be severe as well as fatal.",1,CAS 59-67-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Mefloquine,c1cc2c(cc(nc2c(c1)C(F)(F)F)C(F)(F)F)[C@@H]([C@H]3CCCCN3)O.Cl,Mefloquine therapy is associated with a low rate of transient and asymptomatic serum enzyme elevations and is a rare cause of clinically apparent acute liver injury.,1,CAS 53230-10-7,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Bleomycin,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,"Therapy with bleomycin in combination with other agents is often associated with mild-to-moderate serum enzyme elevations, but is a rare cause of clinically apparent liver injury.",1,CAS 11056-06-7,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Dactinomycin,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,"In high doses, dactinomycin can cause severe liver injury including sinusoidal obstruction syndrome.",1,CAS 50-76-0,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](Cc3c2c(c4c(c3O)C(=O)c5cccc(c5C4=O)OC)O)(C(=O)CO)O)N)O,Doxorubicin is associated with a high rate of transient serum enzyme during therapy and to rare instances of clinically apparent acute liver injury with jaundice that can be severe and even fatal. ,1,CAS 23214-92-8,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Plicamycin,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,"Plicamycin causes acute hepatic injury that arises within days of starting therapy, but is usually transient and asymptomatic and rarely leads to jaundice. ",1,CAS 18378-89-7,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Methotrexate,CN(Cc1cnc2c(n1)c(nc(n2)N)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"When given in high, intravenous doses, methotrexate can cause acute elevations in serum enzymes, and long term methotrexate therapy has been associated with frequent but mild elevations in serum liver enzymes and, more importantly, with development of chronic liver injury, progressive fibrosis, cirrhosis and portal hypertension.",1,CAS 142155-43-9,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Azathioprine,c1(c2c(nc[nH]2)ncn1)Sc1c(ncn1C)[N+](=O)[O-],"Azathioprine is associated with minor, usually transient and asymptomatic elevations in serum aminotransferase levels during therapy and with rare instances of acute, cholestatic liver injury and, with long term use, noncirrhotic portal hypertension as a result of nodular regenerative hyperplasia or sinusoidal obstruction syndrome",1,CAS 446-86-6,0,0,0,0,0,0,1,0,0,0,0,0,train,2
Mercaptopurine,c12c(nc[nH]c1=S)nc[nH]2.O,"Mercaptopurine therapy is associated with a high rate of serum aminotransferase elevations which can be accompanied by jaundice.  In addition, mercaptopurine has been linked to instances of clinically apparent acute liver injury and long term therapy to nodular regenerative hyperplasia.",1,CAS 50-44-2,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Thioguanine,n1c2c(nc[nH]2)c([nH]c1N)=S,"Thioguanine therapy is associated with minor, usually transient and asymptomatic elevations in serum aminotransferase levels and has also been linked to rare instances of cholestatic acute liver injury and to chronic liver injury, resulting in portal hypertension due to nodular regenerative hyperplasia.",1,CAS 154-42-7,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Floxuridine,[C@@H]1(n2c(=O)[nH]c(=O)c(c2)F)O[C@@H]([C@H](C1)O)CO,"Intraarterial floxuridine is associated with a very high rate of serum enzyme and bilirubin elevations during therapy, and with frequent biliary damage that can result in a secondary sclerosing cholangitis, which can be severe and lead to cirrhosis.",1,CAS 50-91-9,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Gemcitabine,[C@H]1(n2c(=O)nc(cc2)N)C([C@@H]([C@H](O1)CO)O)(F)F,"Gemcitabine is associated with a high rate of serum enzyme elevations during therapy but is a very rare cause of acute, clinically apparent liver injury.",1,CAS 95058-81-4,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Tamoxifen,C(=C(/c1ccccc1)CC)(\c1ccc(OCCN(C)C)cc1)c1ccccc1,"Long term tamoxifen therapy has been associated with development of fatty liver, steatohepatitis, cirrhosis, and rare instances of clinically apparent acute liver injury.",1,CAS 10540-29-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Imatinib,C1N(CCN(C1)Cc1ccc(cc1)C(Nc1cc(c(cc1)C)Nc1nccc(n1)c1cccnc1)=O)C,Imatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury which can be severe and has led to fatalities.,1,CAS 152459-95-5,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Thalidomide,O=C(N1C2CCC(NC2=O)=O)C3=CC=CC=C3C1=O,Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.,1,CAS 50-35-1,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Lenalidomide,O=C1NC(=O)CCC1N3C(=O)c2cccc(c2C3)N,Both agents are associated with a low rate of serum aminotransferase elevations during therapy and both have been implicated in causing rare instances of clinically apparent liver injury which can be severe.,1,CAS 191732-72-6,0,0,0,0,1,0,0,0,0,0,0,0,test,2
Tolcapone,Cc1ccc(cc1)C(=O)c1cc(c(c(c1)O)O)[N+](=O)[O-],"Tolcapone has been associated with serum enzyme elevations during treatment and with several instances of clinically apparent acute liver injury, which can be severe and even fatal.",1,CAS 134308-13-7,0,0,0,0,0,0,0,1,0,0,0,0,train,2
Chlorpromazine,CN(C)CCCN1c2ccccc2Sc3c1cc(cc3)Cl,Chlorpromazine can cause mild and transient serum enzyme elevations and is also a well known cause of clinically apparent acute and chronic cholestatic liver injury.,1,CAS 50-53-3,0,0,0,0,0,0,0,0,0,0,0,1,train,2
Perphenazine,c1ccc2c(c1)N(c3cc(ccc3S2)Cl)CCCN4CCN(CC4)CCO,Perphenazine can cause mild and transient serum enzyme elevations and is a rare cause of clinically apparent acute and chronic cholestatic liver injury.,1,CAS 58-39-9,0,0,0,0,0,0,0,0,0,0,0,1,train,2
Prochlorperazine,CN1CCN(CC1)CCCN2c3ccccc3Sc4c2cc(cc4)Cl,"In rare instances, prochlorperazine can cause clinically apparent acute and chronic cholestatic liver injury.",1,CAS 58-38-8,0,0,0,0,0,0,0,0,0,0,0,1,train,2
Trifluoperazine,CN1CCN(CC1)CCCN2c3ccccc3Sc4c2cc(cc4)C(F)(F)F,Trifluoperazine is a rare cause of clinically apparent acute cholestatic liver injury.,1,CAS 117-89-5,0,0,0,0,0,0,0,0,1,0,0,1,train,2
Leflunomide,O=C(Nc1ccc(cc1)C(F)(F)F)c2c(onc2)C,Leflunomide therapy is associated with frequent elevations in serum aminotransferase levels and with rare instances of clinically apparent acute liver injury which can be severe and even fatal.,1,CAS 75706-12-6,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Penicillamine,CC(C)([C@H](C(=O)O)N)S,Penicillamine is capable of causing hypersensitivity reactions some of which are accompanied by liver injury which is typically cholestatic.,1,CAS 52-67-5,0,0,0,0,0,0,1,0,0,0,0,0,test,2
Methimazole,c1(=S)n(cc[nH]1)C,"Methimazole has been linked to serum aminotransferase elevations during therapy as well as to a clinically apparent, idiosyncratic liver injury that is typically cholestatic and self-limited.",1,CAS 60-56-0,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Propylthiouracil,c1(cc(=O)[nH]c(=S)[nH]1)CCC,"Propylthiouracil has been linked to serum aminotransferase elevations during therapy as well as to a clinically apparent, idiosyncratic liver injury that can be severe and even fatal.",1,CAS 51-52-5,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Ethambutol,CC[C@H](CO)NCCN[C@H](CC)CO,"Ethambutol therapy has been associated with minor, transient and asymptomatic elevations in serum aminotransferase levels but is a rare cause of clinically apparent acute liver injury.",1,CAS 74-55-5,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Ethionamide,C(=S)(c1cc(ncc1)CC)N,"Ethionamide has been linked to transient, asymptomatic elevations in serum aminotransferase levels and in uncommon instances of acute liver injury which can be severe.",1,CAS 536-33-4,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Isoniazid,c1(C(=O)NN)ccncc1,"Isoniazid therapy is often associated with minor, transient and asymptomatic elevations in serum aminotransferase levels, but more importanly, isoniazid is a well known cause of acute clinically apparent liver injury which can be severe and is sometimes fatal.",1,CAS 54-85-3,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Pyrazinamide,c1(cnccn1)C(N)=O,"Pyrazinamide is associated with transient and asymptomatic elevations in serum aminotransferase levels and is a well known cause of clinically apparent, acute liver injury that can be severe and even fatal.",1,CAS 98-96-4,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Rifampin,c12c3O[C@@](OC=C[C@@H]([C@@H](C)[C@@H](OC(=O)C)[C@@H]([C@H](O)[C@@H]([C@@H](O)[C@H](C=CC=C(C(=O)Nc4c(c(c(O)c3C)c1c(c4\C=N\N1CCN(CC1)C)O)O)C)C)C)C)OC)(C)C2=O,"Rifampin is associated with transient and asymptomatic elevations in serum aminotransferase and bilirubin levels and is a well known cause of clinically apparent, acute liver disease that can be severe and even fatal.",1,CAS 13292-46-1,0,1,0,0,0,0,0,0,0,0,0,0,test,2
Lansoprazole,c12c(nc([nH]1)[S@@](Cc1c(c(ccn1)OCC(F)(F)F)C)=O)cccc2,Lansoprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a reported but very rare cause of clinically apparent liver injury.,1,CAS 103577-45-3,0,0,0,0,0,1,0,0,1,0,0,0,train,2
Omeprazole,c12c([nH]c(n1)[S@@](Cc1c(c(c(C)cn1)OC)C)=O)ccc(c2)OC,Omeprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a rare cause of clinically apparent liver injury.,1,CAS 73590-58-6,0,0,0,0,0,1,0,0,0,0,0,0,train,2
Pantoprazole,[nH]1c2ccc(cc2nc1[S@@](Cc1nccc(c1OC)OC)=O)OC(F)F,Pantoprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a rare cause of clinically apparent liver injury.,1,CAS 102625-70-7,0,0,0,0,0,1,0,0,1,0,0,0,test,2
Rabeprazole,c12c([n-]c(n1)[S@@](Cc1c(c(ccn1)OCCCOC)C)=O)cccc2.[Na+],Rabeprazole therapy is associated with a low rate of transient and asymptomatic serum aminotransferase elevations and is a rare cause of clinically apparent liver injury.,1,CAS 117976-89-3,0,0,0,0,0,1,0,0,0,0,0,0,train,2
Didanosine,c1[nH]c(=O)c2c(n1)n(cn2)[C@H]3CC[C@H](O3)CO,"Didanosine therapy is associated with an appreciable rate of serum enzyme elevations during therapy, and it is a well established cause of clinically apparent acute liver injury as well as mitochondrial injury to many organs which can be associated with severe liver injury, lactic acidosis and hepatic failure.",1,CAS 69655-05-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Lamivudine,c1cn(c(=O)nc1N)[C@@H]2CS[C@@H](O2)CO,Lamivudine is a very rare cause of clinically apparent drug-induced liver injury but is associated with flares of underlying hepatitis B during therapy or with abrupt withdrawal.,1,CAS 134678-17-4,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Stavudine,Cc1cn(c(=O)[nH]c1=O)[C@H]2C=C[C@H](O2)CO,Stavudine is an uncommon but well established cause of clinically apparent acute liver injury.,1,CAS 3056-17-5,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Zidovudine,Cc1cn(c(=O)[nH]c1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],Zidovudine is a rare but well established cause of clinically apparent liver injury.,1,CAS 30516-87-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Delavirdine,CC(C)Nc1ccnc(c1)N2CCN(CC2)C(=O)c3cc4cc(ccc4[nH]3)NS(=O)(=O)C.CS(=O)(=O)O,Delavirdine is associated with a low rate of transient serum aminotransferase elevations during therapy and is a rare cause of clinically apparent acute liver injury.,1,CAS 136817-59-9,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Efavirenz,c1c(Cl)cc2[C@@](OC(Nc2c1)=O)(C#CC1CC1)C(F)(F)F,Efavirenz is associated with a low rate of serum enzyme elevations during therapy and is an uncommon but well established cause of clinically apparent acute liver injury.,1,CAS 154598-52-4,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Nevirapine,Cc1ccnc2c1NC(=O)c3cccnc3N2C4CC4,"Nevirapine is associated with a high rate of serum aminotransferase elevations during therapy and is a well established cause of acute, clinically apparent liver injury.",1,CAS 129618-40-2,0,0,0,0,0,0,0,0,0,1,0,0,train,2
Indinavir,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](CC(Cc2ccccc2)C(=O)N[C@H]3c4ccccc4C[C@H]3O)O)Cc5cccnc5.OS(=O)(=O)O,"Indinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and mild elevations in indirect bilirubin concentration. Indinavir is a rare cause of clinically apparent, acute liver injury.",1,CAS 150378-17-9,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Lopinavir,c1(ccccc1)C[C@H](NC(COc1c(cccc1C)C)=O)[C@@H](O)C[C@@H](NC([C@@H](N1CCCNC1=O)C(C)C)=O)Cc1ccccc1,"Lopinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and rarely clinically apparent, acute liver injury.",1,CAS 192725-17-0,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Nelfinavir,C1CC[C@H]2[C@@H](C1)C[C@H]([N@@](C2)C[C@@H](O)[C@@H](NC(c1c(c(ccc1)O)C)=O)CSc1ccccc1)C(NC(C)(C)C)=O,"Nelfinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and is a rare cause of clinically apparent, acute liver injury.",1,CAS 159989-64-7,0,0,0,0,0,0,1,0,0,0,0,0,train,2
Ritonavir,C([C@@H](C[C@@H]([C@H](Cc1ccccc1)NC(OCc1cncs1)=O)O)NC([C@@H](NC(N(Cc1nc(C(C)C)sc1)C)=O)C(C)C)=O)c1ccccc1,Ritonavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and rarely can lead to clinically apparent acute liver injury,1,CAS 155213-67-5,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Saquinavir,C1[N@@]([C@@H](C[C@@H]2CCCC[C@@H]12)C(NC(C)(C)C)=O)C[C@H]([C@H](Cc1ccccc1)NC([C@@H](NC(c1nc2c(cccc2)cc1)=O)CC(N)=O)=O)O,Saquinavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and rarely can lead to clinically apparent acute liver injury.,1,CAS 127779-20-8,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Tipranavir,O1[C@@](CCC)(CCc2ccccc2)CC(=C(C1=O)[C@@H](c1cccc(c1)NS(c1ccc(cn1)C(F)(F)F)(=O)=O)CC)O,"Tipranavir can cause transient and usually asymptomatic elevations in serum aminotransferase levels and is a rare cause of clinically apparent, acute liver injury.",1,CAS 174484-41-4,0,0,0,1,0,0,0,0,1,0,0,0,train,2
Betamethasone,F[C@]12[C@H]([C@H]3[C@]([C@](C(CO)=O)(O)[C@H](C3)C)(C)C[C@@H]2O)CCC=2[C@@]1(C=CC(C2)=O)C,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 378-44-9,1,0,0,0,0,0,0,0,1,0,0,0,train,2
Cortisone,C1(CC[C@@]2([C@H]3C(C[C@@]4([C@](CC[C@@H]4[C@@H]3CCC2=C1)(C(CO)=O)O)C)=O)C)=O,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 53-06-5,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Dexamethasone,[C@@]12([C@H]([C@H]3[C@](C[C@@H]2O)([C@]([C@@H](C3)C)(C(=O)CO)O)C)CCC2=CC(=O)C=C[C@]12C)F,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 50-02-2,1,0,0,0,0,0,0,0,1,0,0,0,train,2
Hydrocortisone,C1[C@H]2[C@H]3[C@@H]([C@@]4(C(=CC(=O)CC4)CC3)C)[C@@H](O)C[C@@]2([C@](C(CO)=O)(O)C1)C,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 50-23-7,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Methylprednisolone,[C@H]12[C@H]3[C@@]([C@](CC3)(C(=O)CO)O)(C[C@@H]([C@@H]1[C@@]1(C(=CC(=O)C=C1)[C@H](C2)C)C)O)C,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 83-43-2,1,0,0,0,0,0,0,0,0,0,0,0,test,2
Prednisolone,[C@H]12[C@H]3[C@@H]([C@@]4(C(=CC(=O)C=C4)CC3)C)[C@H](C[C@@]1([C@](CC2)(C(=O)CO)O)C)O,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 50-24-8,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Prednisone,C1[C@H]2[C@H]3[C@@H]([C@@]4(C(=CC(=O)C=C4)CC3)C)C(=O)C[C@@]2([C@](C(CO)=O)(O)C1)C,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 53-03-2,1,0,0,0,0,0,0,0,0,0,0,0,train,2
Triamcinolone,F[C@]12[C@H]([C@H]3[C@]([C@](C(CO)=O)(O)[C@@H](C3)O)(C)C[C@@H]2O)CCC=2[C@@]1(C=CC(C2)=O)C,"Corticosteroid therapy is associated with several forms of liver injury, some due to exacerbation of an underlying liver disease and some that appear to be caused directly by corticosteroid therapy.",1,CAS 124-94-7,1,0,0,0,0,0,0,0,1,0,0,0,train,2
Imipenem,O.N12[C@@H]([C@H]([C@H](C)O)C2=O)CC(=C1C(O)=O)SCCNC=N,"Parenterally administered imipenem/cilastatin has been associated with transient, mild serum aminotransferase elevations, but it is a rare cause of clinically apparent liver disease with jaundice.",1,CAS 74431-23-5,0,0,0,0,0,0,1,0,0,0,0,0,train,2
Meropenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O.O.O.O,"Meropenem is a common cause of mild transient aminotransferase elevations and can rarely result in clinically apparent, cholestatic liver injury.",1,CAS 119478-56-7,0,0,0,0,0,0,1,0,0,0,0,0,train,2
Chlorzoxazone,c1cc2c(cc1Cl)nc(o2)O,"Chlorzoxazone has been linked to rare instances of acute liver injury, a few of which have been fatal.",1,CAS 95-25-0,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Cocaine,CN1[C@H]2CC[C@@H]1[C@@H](C(OC)=O)[C@@H](OC(C3=CC=CC=C3)=O)C2,High doses of cocaine are also associated with toxic reactions including acute liver injury which can be severe and even fatal.,1,CAS 50-36-2,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Dantrolene,c1(c2ccc([N+](=O)[O-])cc2)oc(\C=N\N2CC(=O)NC2=O)cc1,Dantrolene can cause acute liver injury which can be severe and even fatal.,1,CAS 7261-97-4,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Diclofenac,c1cccc(c1CC(=O)O)Nc1c(cccc1Cl)Cl,"Therapy with diclofenac in full doses is frequently associated with mild serum aminotransferase elevations and in rare instances can lead to serious clinically apparent, acute or chronic liver disease.",1,CAS 15307-86-5,0,0,1,0,0,0,0,0,0,0,0,0,train,2
Disulfiram,N(C(=S)SSC(=S)N(CC)CC)(CC)CC,Disulfiram has been associated a low rate of with serum aminotransferase elevations during chronic therapy and has been linked to clinical apparent acute liver injury which can be severe and result in fatality.,1,CAS 97-77-8,0,0,0,0,0,0,1,0,0,0,0,0,train,2
Erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Erythromycin has been linked to rare instances of acute liver injury that are usually self-limited but can result in severe injury and death.,1,CAS 114-07-8,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,"Both etoposide and teniposide are associated with an appreciable rate of serum enzyme elevations during therapy, and high doses have been implicated in causing clinically apparent acute liver injury including sinusoidal obstruction syndrome.",1,CAS 33419-42-0,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Teniposide,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,"Both etoposide and teniposide are associated with an appreciable rate of serum enzyme elevations during therapy, and high doses have been implicated in causing clinically apparent acute liver injury including sinusoidal obstruction syndrome.",1,CAS 29767-20-2,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Usnic acid,C12(c3c(OC1=CC(=O)C(C2=O)C(=O)C)c(c(c(c3O)C)O)C(=O)C)C,"Taken orally, usnic acid can be toxic and has been linked to instances of clinically apparent, acute liver injury.",1,CAS 69-72-7,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Irinotecan,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,Both irinotecan and topotecan are associated with an appreciable rate of serum enzyme elevations during therapy and irinotecan has been implicated in causing steatohepatitis when given as cyclic anticancer therapy.,1,CAS 100286-90-6,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Telithromycin,C1(=O)O[C@@H]([C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@]([C@H]([C@H](C(=O)[C@H]1C)C)O[C@@H]1O[C@@H](C[C@@H]([C@H]1O)N(C)C)C)(OC)C)C)C)N(C(=O)O2)CCCCn1cc(nc1)c1cnccc1)C)CC,Telithromycin was approved for use in the United States in 2004 and subsequently linked to several cases of severe drug-induced liver injury.,1,CAS 191114-48-4,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Minocycline,CN(C)c1ccc(c2c1C[C@H]3C[C@H]4[C@@H](C(=C(C(=O)[C@]4(C(=C3C2=O)O)O)C(=O)N)O)N(C)C)O.Cl,Minocycline can cause both an acute hepatitis like syndrome occurring within 1 to 3 months of starting therapy or a more insidious chronic hepatitis with autoimmune features typically after long-term treatment.,1,CAS 10118-90-8,0,0,0,0,0,0,0,0,0,0,1,0,train,2
Tizanidine,c12c(NC=3NCCN3)c(ccc1nsn2)Cl,"Tizanidine is a commonly used muscle relaxant that has been linked to rare instances of acute liver injury, a few of which have been fatal.",1,CAS 51322-75-9,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Nitrofurantoin,N1(CC(=O)NC1=O)\N=C\c1oc([N+](=O)[O-])cc1,Nitrofurantoin is one of the most common causes of drug induced liver disease and can cause either an acute or a chronic hepatitis-like syndrome that can be severe and lead to liver failure or cirrhosis.,1,CAS 67-20-9,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Sulindac,CC\1=C(c2cc(ccc2/C1=C\c3ccc(cc3)S(=O)C)F)CC(=O)O,"Sulidac is a rare but well established cause of idiosyncratic, clinically apparent drug-induced liver disease.",1,CAS 38194-50-2,0,0,0,0,0,1,0,0,0,0,0,0,train,2
Piroxicam,c12c(S(N(C)C(=C1O)C(Nc1ccccn1)=O)(=O)=O)cccc2,Piroxicam can cause mild serum aminotransferase elevations and in rare instances leads to clinically apparent acute liver injury that can be severe and even fatal.,1,CAS 36322-90-4,0,0,0,1,0,0,0,0,0,0,0,0,train,2
Orlistat,C(=O)([C@@H](NC=O)CC(C)C)O[C@@H](CCCCCCCCCCC)C[C@@H]1OC(=O)[C@H]1CCCCCC,"Orlistat has been linked to rare instances of acute liver injury, some of which have been severe.",1,CAS 96829-58-2,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Vitamin A,C=1(C(CCCC1C)(C)C)\C=C\C(=C\C=C\C(=C\CO)C)C,"Higher doses of vitamin A can be toxic, leading to a constellation of signs and symptoms as well as liver injury, jaundice, enlargement of the liver and spleen, portal hypertension and cirrhosis.",1,CAS 11103-57-4,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Sulfadiazine,c1(S(Nc2ncccn2)(=O)=O)ccc(N)cc1,"  Sulfadiazine, like other sulfonamides, is a well-known cause of clinically apparent, idiosyncratic liver injury.",1,CAS 68-35-9,0,0,0,1,1,0,0,0,0,0,0,0,train,2
Sulfasalazine,c1(S(Nc2ccccn2)(=O)=O)ccc(\N=N\c2cc(c(O)cc2)C(O)=O)cc1,"Sulfasalazine is a rare, but well-known cause of idiosyncratic liver injury.",1,CAS 599-79-1,0,0,0,1,0,0,0,0,0,0,1,0,train,2
Alclofenac,Clc1cc(ccc1OC\C=C)CC(=O)O,Withdrawn due to toxicity (rash/hepatitis),1,CAS   22131-79-9,0,0,1,0,0,0,0,0,0,0,0,0,train,2
Alpidem,Clc3ccc(c1nc2ccc(Cl)cn2c1CC(=O)N(CCC)CCC)cc3,Withdrawn due to toxicity (hepatitis),1,CAS 82626-01-5,0,0,0,0,0,0,0,0,0,0,0,0,test,2
Benoxaprofen,O=C(O)C(c1cc2nc(oc2cc1)c3ccc(Cl)cc3)C,Withdrawn due to toxicity (rash/hepatitis),1,CAS 51234-28-7,0,0,1,0,0,0,0,0,0,0,0,0,train,2
Bromfenac,O=C(c1ccc(Br)cc1)c2cccc(c2N)CC(=O)O,Withdrawn due to toxicity (hepatitis),1,CAS 91714-94-2,0,0,1,0,1,0,0,1,0,0,0,0,train,2
Ibufenac,CC(C)CC1=CC=C(C=C1)CC(=O)O,Withdrawn due to toxicity (hepatitis),1,CAS 1553-60-2,0,0,1,0,0,0,0,0,0,0,0,0,train,2
iproniazid,O=C(NNC(C)C)c1ccncc1,Withdrawn due to toxicity (hepatitis),1,CAS 54-92-2,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Nomifensine,NC1=C(CN(C)CC2C3=CC=CC=C3)C2=CC=C1,Withdrawn due to toxicity (hepatitis),1,CAS 24526-64-5,0,0,0,0,1,0,0,0,0,0,0,0,train,2
Sudoxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=NC=CS3,Withdrawn due to toxicity (hepatitis),1,CAS 251-808-7,0,0,0,1,0,0,0,0,0,0,0,0,test,2
Tienilic acid,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl,Withdrawn due to toxicity (hepatitis),1,CAS 40180-04-9,0,0,0,0,0,0,0,1,0,0,0,0,train,2
Tolrestat,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,Withdrawn due to toxicity (hepatitis),1,CAS 4434-05-3,0,0,0,0,0,0,0,0,1,0,0,0,train,2
Zomepirac,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,Withdrawn due to toxicity (rash/hepatitis),1,CAS 33369-31-2,0,0,1,0,0,0,0,1,0,0,0,0,test,2
amineptine,C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O,Withdrawn due to toxicity (hepatitis),1,CAS 57574-09-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
clometacin,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,Withdrawn due to toxicity (hepatitis),1,CAS 25803-14-9,0,0,1,0,0,0,0,1,0,0,0,0,train,2
fenclofenac,C1=CC=C(C(=C1)CC(=O)O)OC2=C(C=C(C=C2)Cl)Cl,Withdrawn due to toxicity (hepatitis),1,CAS 34645-84-6,0,0,1,0,0,0,0,0,0,0,0,0,train,2
fenclozic acid,C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl,Withdrawn due to toxicity (hepatitis),1,CAS 17969-20-9,0,0,1,0,0,0,0,0,0,0,0,0,train,2
lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,Withdrawn due to toxicity (hepatitis),1,CAS 220991-20-8,0,0,1,0,0,0,0,0,0,0,0,0,train,2
pirprofen,CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O,Withdrawn due to toxicity (hepatitis),1,CAS 31793-07-4,0,0,1,0,0,0,0,0,0,0,0,0,train,2
ebrotidine,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,Withdrawn due to toxicity (hepatitis),1,CAS   100981-43-9,0,0,0,1,0,0,1,0,0,0,0,0,train,2
niperotidine,CN(C)CC1=CC=C(O1)CSCCNC(=C[N+](=O)[O-])NCC2=CC3=C(C=C2)OCO3,Withdrawn due to toxicity (hepatitis),1,CAS 84845-75-0,0,0,0,0,0,0,1,0,0,0,0,0,train,2
pipamazine,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Withdrawn due to toxicity (hepatitis),1,CAS   84-04-8,0,0,0,0,0,0,0,0,0,0,0,1,train,2
ximelagatran,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N,Withdrawn due to toxicity (hepatitis),1,CAS 192939-46-1,0,0,0,0,0,0,0,0,0,0,0,0,train,2
benziodarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)O)I,Withdrawn due to toxicity (hepatitis),1,CAS 68-90-6,0,0,0,0,0,0,0,1,0,0,0,0,train,2
oxyphenisatin,C1=CC=C2C(=C1)C(C(=O)N2)(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,Withdrawn due to toxicity (hepatitis),1,CAS 125-13-3,0,0,0,0,0,0,0,0,0,0,0,0,train,2
pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,Withdrawn due to toxicity (hepatitis),1,CAS   2152-34-3,0,0,0,0,0,0,0,0,0,0,0,0,train,2
Trovafloxacin,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,Withdrawn due to toxicity (hepatitis),1,CAS 147059-72-1,0,0,0,0,0,0,0,0,0,1,0,0,train,2
Deferasirox,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,Blackbox warning for heptatotoxicity,1,CAS 201530-41-8,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N/N=C/3\C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,Blackbox warning for heptatotoxicity,1,CAS 443130-00-5,0,1,0,0,0,0,0,0,0,0,0,0,train,2
Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,Blackbox warning for heptatotoxicity,1,CAS 444731-52-6,0,0,0,0,0,0,0,0,0,0,0,0,train,2
